Cover Page
Cover Page - shares | 9 Months Ended | |
Jun. 30, 2021 | Jul. 30, 2021 | |
Document Information [Line Items] | ||
Document Type | 10-Q | |
Amendment Flag | false | |
Document Quarterly Report | true | |
Document Transition Report | false | |
Document Fiscal Period Focus | Q3 | |
Document Fiscal Year Focus | 2021 | |
Document Period End Date | Jun. 30, 2021 | |
Current Fiscal Year End Date | --09-30 | |
Entity Registrant Name | AZEK Co Inc. | |
Entity Central Index Key | 0001782754 | |
Entity File Number | 001-39322 | |
Entity Tax Identification Number | 90-1017663 | |
Entity Interactive Data Current | Yes | |
Entity Current Reporting Status | Yes | |
Entity Shell Company | false | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | false | |
Entity Incorporation, State or Country Code | DE | |
Entity Emerging Growth Company | true | |
Entity Ex Transition Period | false | |
Entity Address, Address Line One | 1330 W Fulton Street, Suite 350 | |
Entity Address, City or Town | Chicago | |
Entity Address, State or Province | IL | |
Entity Address, Postal Zip Code | 60607 | |
City Area Code | 877 | |
Local Phone Number | 275-2935 | |
Title of 12(b) Security | Class A Common Stock, par value $0.001 per share | |
Trading Symbol | AZEK | |
Security Exchange Name | NYSE | |
Common Class A [Member] | ||
Document Information [Line Items] | ||
Entity Common Stock, Shares Outstanding | 154,842,197 | |
Common Class B [Member] | ||
Document Information [Line Items] | ||
Entity Common Stock, Shares Outstanding | 100 |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Jun. 30, 2021 | Sep. 30, 2020 |
Current assets: | ||
Cash and cash equivalents | $ 220,464 | $ 215,012 |
Trade receivables, net of allowances | 90,186 | 70,886 |
Inventories | 172,791 | 130,070 |
Prepaid expenses | 10,207 | 8,367 |
Other current assets | 498 | 360 |
Total current assets | 494,146 | 424,695 |
Property, plant and equipment - net | 341,685 | 261,774 |
Goodwill | 951,390 | 951,390 |
Intangible assets - net | 254,708 | 292,374 |
Other assets | 2,046 | 1,623 |
Total assets | 2,043,975 | 1,931,856 |
Current liabilities: | ||
Accounts payable | 49,736 | 42,059 |
Accrued rebates | 32,820 | 30,362 |
Accrued interest | 1,103 | 1,103 |
Accrued expenses and other liabilities | 53,910 | 50,516 |
Total current liabilities | 137,569 | 124,040 |
Deferred income taxes | 38,645 | 21,260 |
Finance lease obligation—less current portion | 10,505 | 10,910 |
Long-term debt—less current portion | 464,431 | 462,982 |
Other non-current liabilities | 10,652 | 8,776 |
Total liabilities | 661,802 | 627,968 |
Commitments and contingencies (See Note 15) | ||
Stockholders' equity: | ||
Preferred stock, $0.001 par value; 1,000,000 shares authorized and no shares issued or outstanding at June 30, 2021 and September 30, 2020, respectively | ||
Additional paid‑in capital | 1,610,884 | 1,587,208 |
Accumulated deficit | (228,866) | (283,475) |
Total stockholders' equity | 1,382,173 | 1,303,888 |
Total liabilities and stockholders' equity | 2,043,975 | 1,931,856 |
Common Class A [Member] | ||
Stockholders' equity: | ||
Common stock | 155 | 155 |
Total stockholders' equity | $ 155 | $ 155 |
Condensed Consolidated Balanc_2
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares | Jun. 30, 2021 | Sep. 30, 2020 |
Preferred stock, par value per share | $ 0.001 | $ 0.001 |
Preferred stock, shares authorized | 1,000,000 | 1,000,000 |
Preferred stock, shares issued | 0 | 0 |
Preferred stock, shares outstanding | 0 | 0 |
Common Class A [Member] | ||
Common stock, par value per share | $ 0.001 | $ 0.001 |
Common stock, shares authorized | 1,100,000,000 | 1,100,000,000 |
Common stock, shares issued | 154,829,153 | 154,637,240 |
Common stock, shares outstanding | 154,829,153 | 154,637,240 |
Common Class B [Member] | ||
Common stock, par value per share | $ 0.001 | $ 0.001 |
Common stock, shares authorized | 100,000,000 | 100,000,000 |
Common stock, shares issued | 100 | 100 |
Common stock, shares outstanding | 100 | 100 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | |
Statement Of Income And Comprehensive Income [Abstract] | ||||
Net sales | $ 327,454 | $ 223,711 | $ 832,854 | $ 635,339 |
Cost of sales | 220,587 | 148,588 | 555,147 | 429,553 |
Gross profit | 106,867 | 75,123 | 277,707 | 205,786 |
Selling, general and administrative expenses | 70,300 | 65,164 | 183,226 | 158,330 |
Other general expenses | 1,443 | 1,623 | 2,592 | 6,716 |
Loss (gain) on disposal of property, plant and equipment | 325 | 366 | 624 | 394 |
Operating income (loss) | 34,799 | 7,970 | 91,265 | 40,346 |
Other expenses: | ||||
Interest expense | 4,219 | 25,148 | 16,931 | 64,882 |
Loss on extinguishment of debt | 37,538 | 37,538 | ||
Total other expenses | 4,219 | 62,686 | 16,931 | 102,420 |
Income (loss) before income taxes | 30,580 | (54,716) | 74,334 | (62,074) |
Income tax expense (benefit) | 8,811 | (2,600) | 19,725 | (4,200) |
Net income (loss) | $ 21,769 | $ (52,116) | $ 54,609 | $ (57,874) |
Net income (loss) per common share - basic | $ 0.14 | $ 0.44 | $ 0.36 | $ (0.51) |
Net income (loss) per common share - diluted | $ 0.14 | $ 0.44 | $ 0.35 | $ (0.51) |
Comprehensive income (loss) | $ 21,769 | $ (52,116) | $ 54,609 | $ (57,874) |
Weighted-average common shares outstanding - basic and diluted | ||||
Basic | 153,854,313 | 118,738,357 | 153,623,579 | 113,525,537 |
Diluted | 157,022,043 | 118,738,357 | 156,658,640 | 113,525,537 |
Condensed Consolidated Statem_2
Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands | Total | Adoption of ASU [Member] | Common Class A [Member] | Common Class B [Member] | Additional Paid-in Capital [Member] | Accumulated Deficit [Member] | Accumulated Deficit [Member]Adoption of ASU [Member] |
Beginning balance at Sep. 30, 2019 | $ 490,023 | $ 75 | $ 33 | $ 652,493 | $ (162,578) | ||
Beginning balance (in shares) at Sep. 30, 2019 | 75,093,778 | 33,068,963 | |||||
Adoption of ASU 2016-16 | $ 1,336 | $ 1,336 | |||||
Net income (loss) | (57,874) | (57,874) | |||||
Stock-based compensation | 18,670 | 18,670 | |||||
Conversion of profit interests into common shares | $ 9 | (9) | |||||
Conversion of profit interests into common shares (in shares) | 8,235,299 | ||||||
Net proceeds from initial public offering | 819,411 | $ 38 | 819,373 | ||||
Net proceeds from initial public offering (in shares) | 38,237,500 | ||||||
Member contributions prior to initial public offering | 1,500 | 1,500 | |||||
Member redemptions prior to initial public offering | (3,553) | (3,553) | |||||
Ending balance at Jun. 30, 2020 | 1,269,513 | $ 122 | $ 33 | 1,488,474 | (219,116) | ||
Ending balance (in shares) at Jun. 30, 2020 | 121,566,577 | 33,068,963 | |||||
Beginning balance at Mar. 31, 2020 | 485,406 | $ 75 | $ 33 | 652,298 | (167,000) | ||
Beginning balance (in shares) at Mar. 31, 2020 | 75,093,778 | 33,068,963 | |||||
Net income (loss) | (52,116) | (52,116) | |||||
Stock-based compensation | 17,289 | 17,289 | |||||
Conversion of profit interests into common shares | $ 9 | (9) | |||||
Conversion of profit interests into common shares (in shares) | 8,235,299 | ||||||
Net proceeds from initial public offering | 819,411 | $ 38 | 819,373 | ||||
Net proceeds from initial public offering (in shares) | 38,237,500 | ||||||
Member redemptions prior to initial public offering | (477) | (477) | |||||
Ending balance at Jun. 30, 2020 | 1,269,513 | $ 122 | $ 33 | 1,488,474 | (219,116) | ||
Ending balance (in shares) at Jun. 30, 2020 | 121,566,577 | 33,068,963 | |||||
Beginning balance at Sep. 30, 2020 | 1,303,888 | $ 155 | 1,587,208 | (283,475) | |||
Beginning balance (in shares) at Sep. 30, 2020 | 154,637,240 | 100 | |||||
Net income (loss) | 54,609 | 54,609 | |||||
Stock-based compensation | 19,272 | 19,272 | |||||
Exercise of vested stock options | 4,614 | 4,614 | |||||
Exercise of vested stock options (in shares) | 213,908 | ||||||
Cancellation of restricted stock awards (in shares) | (21,995) | ||||||
IPO costs | (210) | (210) | |||||
Ending balance at Jun. 30, 2021 | 1,382,173 | $ 155 | 1,610,884 | (228,866) | |||
Ending balance (in shares) at Jun. 30, 2021 | 154,829,153 | 100 | |||||
Beginning balance at Mar. 31, 2021 | 1,349,403 | $ 155 | 1,599,883 | (250,635) | |||
Beginning balance (in shares) at Mar. 31, 2021 | 154,739,238 | 100 | |||||
Net income (loss) | 21,769 | 21,769 | |||||
Stock-based compensation | 9,340 | 9,340 | |||||
Exercise of vested stock options | 1,661 | 1,661 | |||||
Exercise of vested stock options (in shares) | 89,915 | ||||||
Ending balance at Jun. 30, 2021 | $ 1,382,173 | $ 155 | $ 1,610,884 | $ (228,866) | |||
Ending balance (in shares) at Jun. 30, 2021 | 154,829,153 | 100 |
Condensed Consolidated Statem_3
Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands | 9 Months Ended | |
Jun. 30, 2021 | Jun. 30, 2020 | |
Operating activities: | ||
Net income (loss) | $ 54,609 | $ (57,874) |
Adjustments to reconcile net income (loss) to net cash flows provided by (used in) operating activities: | ||
Depreciation | 37,588 | 33,603 |
Amortization of intangibles | 37,666 | 41,622 |
Non-cash interest expense | 1,940 | 6,527 |
Deferred income tax (benefit) provision | 17,385 | (4,048) |
Non-cash compensation expense | 19,272 | 18,670 |
Loss (gain) on disposal of property, plant and equipment | 624 | 394 |
Bad debt provision | 271 | 522 |
Loss on extinguishment of debt | 37,538 | |
Changes in certain assets and liabilities: | ||
Trade receivables | (19,571) | (26,385) |
Inventories | (42,722) | (12,703) |
Prepaid expenses and other currents assets | (1,978) | (4,130) |
Accounts payable | 6,911 | (12,753) |
Accrued expenses and interest | 4,832 | (8,592) |
Other assets and liabilities | 1,901 | (1,105) |
Net cash provided by (used in) operating activities | 118,728 | 11,286 |
Investing activities: | ||
Purchases of property, plant and equipment | (116,037) | (54,768) |
Proceeds from disposition of fixed assets | 38 | 223 |
Acquisition, net of cash acquired | (18,453) | |
Net cash provided by (used in) investing activities | (115,999) | (72,998) |
Financing activities: | ||
Proceeds from initial public offering, net of related costs | (210) | 822,630 |
Proceeds from 2025 Senior Notes | 346,500 | |
Redemption of Senior Notes | (665,000) | |
Payments of debt extinguishment costs | (24,938) | |
Proceeds under revolving credit facility | 129,000 | |
Payments under revolving credit facility | (85,000) | |
Payments on long-term debt obligations | (341,958) | |
Payment of debt issuance costs | (938) | (7,704) |
Proceeds (repayments) of finance lease obligations | (743) | (601) |
Exercise of vested stock options | 4,614 | |
Redemption of capital contributions | (3,553) | |
Capital contribution from members | 1,500 | |
Net cash provided by (used in) financing activities | 2,723 | 170,876 |
Net increase (decrease) in cash and cash equivalents | 5,452 | 109,164 |
Cash and cash equivalents – Beginning of period | 215,012 | 105,947 |
Cash and cash equivalents – End of period | 220,464 | 215,111 |
Supplemental cash flow disclosure: | ||
Cash paid for interest, net of amounts capitalized | 14,871 | 70,801 |
Cash paid for income taxes, net | 2,458 | 544 |
Supplemental non-cash investing and financing disclosure: | ||
Capital expenditures in accounts payable at end of period | 3,780 | 5,058 |
Property, plant and equipment acquired under finance leases | $ 569 | $ 630 |
Organization and Summary of Sig
Organization and Summary of Significant Accounting Policies | 9 Months Ended |
Jun. 30, 2021 | |
Organization Consolidation And Presentation Of Financial Statements [Abstract] | |
Organization and Summary of Significant Accounting Policies | 1. ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES a. Organization The AZEK Company Inc. (the “Company”) is a Delaware corporation that holds all of the limited liability company interests in CPG International LLC, the entity which directly and indirectly holds all of the equity interests in the operating subsidiaries. The Company is a leading manufacturer of premium, low-maintenance building products for residential, commercial and industrial markets. The Company’s products include trim, decking, porch, moulding, railing, pavers, bathroom and locker systems, as well as extruded plastic sheet products and other non-fabricated products for special applications in industrial markets. The Company operates in various locations throughout the United States. AZEK is a brand name for residential products while the commercial products are branded under the brand names Celtec, Playboard, Seaboard, Flametec, Designboard, Cortec, Sanatec, Scranton Products, Aria Partitions, Eclipse Partitions, Hiny Hiders, Tufftec Lockers and Duralife Lockers. Initial Public Offering On June 16, 2020, the Company completed its initial public offering (the “IPO”) of its Class A common stock, in which it sold 38,237,500 shares, including 4,987,500 shares pursuant to the underwriters’ over-allotment option. The shares began trading on the New York Stock Exchange on June 12, 2020 under the symbol “AZEK”. The shares were sold at an IPO price of $23.00 per share for net proceeds to the Company of approximately $819.7 million, after deducting underwriting discounts and commissions of $50.6 million and offering expenses of approximately $9.2 million payable by the Company. In addition, the Company used its net proceeds to redeem $350.0 million in aggregate principal of its then-outstanding 2025 Senior Notes, $70.0 million of its then-outstanding principal amount under the Revolving Credit Facility and effected a $337.7 million prepayment of its then-outstanding principal amount under the Term Loan Agreement. In conjunction with the Company’s conversion from a limited liability company into a corporation (the “Corporate Conversion”) prior to the closing of the IPO, the Company effected a unit split of its then-outstanding limited liability company unit and then converted the units on a one-to-one basis into shares of capital stock of the Company, including shares of Class A common stock and Class B common stock. In connection with the closing of the IPO, the Company issued additional shares of its Class A common stock, options to purchase shares of Class A common stock and certain other equity awards to its indirect equity holders prior to the IPO and certain of its officers and employees. All share and per share information presented in the Consolidated Financial Statements has been retroactively adjusted for all periods presented for the effects of the unit split converted to stock. Refer to Note 11 and 12 for additional information. Secondary Offerings On September 15, 2020, the Company completed an offering of 28,750,000 shares of Class A common stock, par value $0.001 per share, including the exercise in full by the underwriters of their option to purchase up to 3,750,000 additional shares of Class A common stock, at a public offering price of $33.25 per share. The shares were sold by certain stockholders of the Company (the “Selling Stockholders”). The Company did not receive any of the proceeds from the sale of the shares by the Selling Stockholders. Immediately subsequent to the closing of the secondary offering, Class B common stockholders converted 33,068,863 shares of Class B common stock into Class A common stock. In addition, the secondary offering triggered a change in performance criteria, in which certain performance-vested restricted stock awards and stock options vested as a result of the secondary offering. Refer to Note 11 and 12 for additional information. On January 26, 2021, the Company completed an offering of 20,000,000 shares of Class A common stock, par value $0.001 per share, including the exercise in full by the underwriters of their option to purchase up to 3,000,000 additional shares of Class A common stock, at a public offering price of $40.00 per share. The shares were sold by certain of the Selling Stockholders. The Company did not receive any of the proceeds from the sale of the shares by those Selling Stockholders. In connection with the offering the Company incurred approximately $1.2 million in expenses. On June 1, 2021, the Company completed an offering of 17,250,000 shares of Class A common stock, par value $0.001 per share, including the exercise in full by the underwriters of their option to purchase up to 2,250,000 additional shares of Class A common stock, at a public offering price of $43.50 per share. The shares were sold by certain of the Selling Stockholders. The Company did not receive any of the proceeds from the sale of the shares by those Selling Stockholders. In connection with the offering the Company incurred approximately $ million in expenses. b. Summary of Significant Accounting Policies Basis of Presentation The Company operates on a fiscal year ending September 30. The accompanying unaudited Condensed Consolidated Financial Statements and notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information, and in management’s opinion, includes all adjustments, consisting of only normal recurring adjustments, necessary for the fair statement of the Company’s financial position, its results of operations and cash flows for the interim periods presented. The results of operations for the three and nine months ended June 30, 2021 and the cash flows for the nine months ended June 30, 2021 are not necessarily indicative of the results to be expected for the full fiscal year or any other period. The Company’s financial condition and results of operations are being, and are expected to continue to be affected by the current COVID-19 public health pandemic. The economic effects of the COVID-19 pandemic will likely continue to affect demand for the Company’s products in the foreseeable future. Although management has implemented measures to mitigate any impact of the COVID-19 pandemic on the Company’s business, financial condition and results of operations, these measures may not fully mitigate the impact of the COVID-19 pandemic on the Company’s business, financial condition and results of operations. Management cannot predict the degree to, or the period over, which the Company will be affected by the COVID-19 pandemic and resulting governmental and other measures. The accompanying unaudited Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and notes thereto included in the Company’s 2020 Form 10-K. The Condensed Consolidated Balance Sheet as of September 30, 2020 was derived from the audited financial statements at that date. There have been no material changes in the Company’s significant accounting policies from those that were disclosed in the 2020 Form 10-K, except as noted below. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Significant estimates include revenue recognition, reserves for excess inventory, inventory obsolescence, product warranties, customer rebates, stock-based compensation, litigation, income taxes, contingent consideration, goodwill and intangible asset valuation and accounting for long-lived assets. Management’s estimates and assumptions are evaluated on an ongoing basis and are based on historical experience, current conditions and available information. Actual results may differ from estimated amounts. Estimates are revised as additional information becomes available. Accounting Policies Refer to the Company’s 2020 Form 10-K for a discussion of the Company’s accounting policies, as updated below and for recently adopted accounting standards. Research and Development Costs Research and development costs primarily relate to new product development, product claims support and manufacturing process improvements. Such costs are expensed as incurred and are included in “Selling, general and administrative expenses” within the Condensed Consolidated Statements of Comprehensive Income (Loss). Total research and development expenses were approximately $1.9 million and $1.7 million, respectively, for the three months ended June 30, 2021 and 2020, and approximately $5.5 million and $5.7 million, respectively, for the nine months ended June 30, 2021 and 2020. Recently Adopted Accounting Pronouncements Under the Jumpstart Our Business Startups (“JOBS”) Act, the Company qualifies as an emerging growth company (“EGC”) and as such, has elected not to opt out of the extended transition period for complying with new or revised accounting pronouncements. During the extended transition period, the Company is not subject to new or revised accounting standards applicable to public companies. The accounting pronouncements pending adoption below reflect effective dates for the Company as an EGC with the extended transition period. Based on our public float calculation at March 31, 2021, the Company will be deemed a Large Accelerated Filer under the U.S. Securities and Exchange Commission guidelines and will cease to qualify as an EGC effective September 30, 2021. The loss of EGC status will result in losing the reporting exemptions noted above, and in particular will require our independent registered public accounting firm to provide an attestation report on the effectiveness of our internal control over financial reporting as of and for the year ended September 30, 2021 under Section 404(b) of the Sarbanes-Oxley Act. On October 1, 2019, the Company adopted ASU No. 2016-16, Income Taxes (Topic 740): Intra-Entity Transfer of Assets Other Than Inventory On October 1, 2020, the Company adopted ASU No. 2018-13, Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement, Fair Value Measurement Recently Issued Accounting Pronouncements In February 2016, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2016-02, Leases (Topic 842), In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments—Credit Losses (Topic 326) In August 2018, the FASB issued ASU No. 2018-15, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740)—Simplifying the Accounting for Income Taxes of the amendments is permitted, including adoption in any interim period for (1) public business entities for periods for which financial statements have not yet been issued and (2) all other entities for periods for which financial statements have not yet been made available for issuance. An entity that elects to early adopt the amendments in an interim period should reflect any adjustments as of the beginning of the annual period that includes that interim period. Additionally, an entity that elects early adoption must adopt all the amendments in the same period. The amendments are applied on a prospective or retrospective basis, depending upon the amendment adopted within this ASU. The amendments in this ASU are effective for the Company for annual period s ending September 30, 2021 and thereafter and interim periods within annual periods beginning October 1, 2021 . The Company is currently evaluating the impact this adoption will have on its Consolidated Financial Statements. In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting |
Revenue
Revenue | 9 Months Ended |
Jun. 30, 2021 | |
Revenue From Contract With Customer [Abstract] | |
Revenue | 2. REVENUE The Company recognizes revenues when control of the promised goods is transferred to the Company’s customers in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods, at a point in time, when shipping occurs. The Company also engages in customer rebates, which are recorded in “Net sales” in the Condensed Consolidated Statements of Comprehensive Income (Loss) and in “Accrued rebates” and Trade receivables in the Condensed Consolidated Balance Sheets. The Company recorded accrued rebates of $32.8 million and $22.8 million as of June 30, 2021 and 2020, respectively, and contra trade receivables of $3.4 million and $3.0 million as of June 30, 2021 and 2020, respectively. The rebate activity was as follows (in thousands): Three Months Ended June 30, Nine Months Ended June 30, 2021 2020 2021 2020 Beginning balance $ 27,791 $ 22,123 $ 32,679 $ 24,858 Rebate expense 20,645 11,545 54,857 44,989 Rebate payments (12,257 ) (7,844 ) (51,357 ) (44,023 ) Ending balance $ 36,179 $ 25,824 $ 36,179 $ 25,824 The Company records deferred revenue when cash payments are received or due in advance of the Company’s performance. |
Inventories
Inventories | 9 Months Ended |
Jun. 30, 2021 | |
Inventory Disclosure [Abstract] | |
Inventories | 3. INVENTORIES Inventories are valued at the lower of cost or net realizable value, and are reduced for slow-moving and obsolete inventory. The inventories cost is recorded at standard cost, which approximates actual cost, on a first-in first-out “FIFO”) basis. Inventories consisted of the following (in thousands): in thousands June 30, 2021 September 30, 2020 Raw materials $ 39,417 $ 33,850 Work in process 24,371 19,935 Finished goods 109,003 76,285 Total inventories $ 172,791 $ 130,070 |
Property, Plant and Equipment -
Property, Plant and Equipment - Net | 9 Months Ended |
Jun. 30, 2021 | |
Property Plant And Equipment [Abstract] | |
Property, Plant and Equipment - Net | 4. PROPERTY, PLANT AND EQUIPMENT—NET Property, plant and equipment – net consisted of the following (in thousands): June 30, 2021 September 30, 2020 Land and improvements $ 2,758 $ 2,758 Buildings and improvements 77,083 71,059 Capital lease – building 2,021 2,021 Capital lease – manufacturing equipment 1,026 1,026 Capital lease – vehicles 4,050 3,782 Manufacturing equipment 389,503 306,036 Computer equipment 27,301 24,927 Furniture and fixtures 6,013 5,689 Vehicles 588 465 Total property and equipment 510,343 417,763 Construction in progress 77,705 54,412 588,048 472,175 Accumulated depreciation (246,363 ) (210,401 ) Total property and equipment – net $ 341,685 $ 261,774 The Company is considered the owner, for accounting purposes only, of leased office space, as it had taken on certain risks of construction build cost overages above normal tenant improvement allowances. Accordingly, the estimated fair value of the leased property was $9.2 million as of both June 30, 2021 and September 30, 2020. The corresponding lease financing obligation was $7.9 million as of both June 30, 2021 and September 30, 2020. The lease financing obligation was recorded in “Finance lease obligations – less current portion” in the Condensed Consolidated Balance Sheets. Refer to Note 15 for additional information. Depreciation expense was approximately $13.3 million and $12.7 million in the three months ended June 30, 2021 and 2020, respectively, and $37.6 million and $33.6 million in the nine months ended June 30, 2021 and 2020, respectively. During the three months ended June 30, 2021 and 2020, $0.5 million and $0.3 million of interest was capitalized, respectively, and during the nine months ended June 30, 2021 and 2020, $1.4 million and $0.8 million of interest was capitalized, respectively. Accumulated amortization for assets under capital leases was $4.6 million and $4.0 million as of June 30, 2021 and September 30, 2020, respectively. Accumulated amortization for assets under the build-to-suit lease was $0.8 million as of June 30, 2021 and $0.5 million as of September 30, 2020. |
Goodwill and Intangible Assets
Goodwill and Intangible Assets - Net | 9 Months Ended |
Jun. 30, 2021 | |
Goodwill And Intangible Assets Disclosure [Abstract] | |
Goodwill and Intangible Assets - Net | 5. GOODWILL AND INTANGIBLE ASSETS—NET Goodwill As of both June 30, 2021 and September 30, 2020, the Company had goodwill of $951.4 million with carrying amounts for Residential of $911.0 million and Commercial of $40.4 million. As of June 30, 2021, total accumulated goodwill impairments were $32.2 million, all attributable to the Company’s Commercial segment. Intangible assets, net The Company does not have any indefinite lived intangible assets other than goodwill as of June 30, 2021 and September 30, 2020. Finite-lived intangible assets consisted of the following (in thousands): June 30, 2021 Lives in Years Gross Carrying Value Accumulated Amortization Net Carrying Value Proprietary knowledge 10 - 15 $ 289,300 $ (211,114 ) $ 78,186 Trademarks 5 - 20 223,840 (135,904 ) 87,936 Customer relationships 15 - 19 146,670 (61,434 ) 85,236 Patents 10 7,000 (3,882 ) 3,118 Other intangibles 3 - 15 4,076 (3,844 ) 232 Total intangible assets $ 670,886 $ (416,178 ) $ 254,708 September 30, 2020 Lives in Years Gross Carrying Value Accumulated Amortization Net Carrying Value Propriety knowledge 10 — 15 $ 289,300 $ (195,303 ) $ 93,997 Trademarks 5 — 20 223,840 (124,521 ) 99,319 Customer relationships 15 — 19 146,670 (52,119 ) 94,551 Patents 10 7,000 (3,182 ) 3,818 Other intangible assets 3 — 15 4,076 (3,387 ) 689 Total intangible assets $ 670,886 $ (378,512 ) $ 292,374 Amortization expense was approximately $12.5 million and $13.9 million in the three months ended June 30, 2021 and 2020, respectively, and $37.7 million and $41.6 million in the nine months ended June 30, 2021 and 2020, respectively. As of June 30, 2021, the remaining weighted-average amortization period for acquired intangible assets was 12.4 years. |
Composition of Certain Balance
Composition of Certain Balance Sheet Accounts | 9 Months Ended |
Jun. 30, 2021 | |
Composition Of Certain Balance Sheet Accounts Disclosure [Abstract] | |
Composition of Certain Balance Sheet Accounts | 6. COMPOSITION OF CERTAIN BALANCE SHEET ACCOUNTS Allowance for Doubtful Accounts Allowance for doubtful accounts consisted of the following (in thousands): Three Months Ended June 30, Nine Months Ended June 30, 2021 2020 2021 2020 Beginning balance $ 1,487 $ 1,678 $ 1,332 $ 904 Provision 116 (229 ) 271 522 Bad debt write-offs (540 ) (107 ) (540 ) (119 ) Acquisition — — — 35 Ending balance $ 1,063 $ 1,342 $ 1,063 $ 1,342 Accrued Expenses and Other Liabilities Accrued expenses consisted of the following (in thousands): June 30, 2021 September 30, 2020 Employee related liabilities $ 30,949 $ 26,554 Freight 3,277 5,530 Professional fees 4,030 4,249 Marketing 3,491 3,343 Warranty 2,977 2,921 Construction in progress 2,250 1,303 Capital lease 1,064 969 Manufacturing related accruals 1,816 1,664 Other 4,056 3,983 Ending balance $ 53,910 $ 50,516 |
Debt
Debt | 9 Months Ended |
Jun. 30, 2021 | |
Debt Disclosure [Abstract] | |
Debt | 7. DEBT Debt consisted of the following (in thousands): June 30, 2021 September 30, 2020 Term Loan due May 5, 2024 — LIBOR + 2.50% (3.25% at June 30, 2021) and LIBOR + 3.75% (4.75% at September 30, 2020), (includes a discount of $344 and $507 at June 30, 2021 and September 30, 2020, respectively) $ 467,310 $ 467,147 Revolving Credit Facility through March 31, 2026 - LIBOR + 1.25% at June 30, 2021 and LIBOR +2.00% at September 30, 2020 — — Senior Notes due October 1, 2021 — Fixed at 8% — — Total 467,310 467,147 Less unamortized deferred financing costs (2,879 ) (4,165 ) Less current portion — — Long-term debt—less current portion and unamortized deferred financing costs $ 464,431 $ 462,982 Term Loan Agreement The term loan agreement, as amended and restated from time to time (the “Term Loan Agreement”), is a first lien term loan originally entered into on September 30, 2013 by the Company’s wholly-owned subsidiary, CPG International LLC (as successor-in-interest to CPG Merger Sub LLC), as the initial borrower with a syndicate of lenders party thereto. As of June 30, 2021 and September 30, 2020, CPG International LLC had $467.7 million outstanding under the Term Loan Agreement. The Term Loan Agreement matures on May 5, 2024. The obligations under the Term Loan Agreement are secured by a first priority security interest in the membership interests of CPG International LLC owned by the Company and substantially all of the present and future assets of the borrowers and guarantors named therein including equity interests of their domestic subsidiaries, subject to certain exceptions, (the “Term Loan Priority Collateral”) and a second priority lien on current assets. The obligations under the Term Loan Agreement are guaranteed by the Company and the wholly owned domestic subsidiaries of CPG International LLC other than certain immaterial subsidiaries and other excluded subsidiaries. On February 2, 2021, the Company entered into an amendment to the Term Loan Agreement. The amendment effected through reducing (i) the ABR floor by 25 basis points from 2.0% to 1.75%, (ii) the Adjusted LIBOR Rate floor by 25 basis points from 1.0% to 0.75% and (iii) the Applicable Margin with respect to any Effective Date Term Loans, by up to 125 basis points from 3.75% to 2.50% in the case of any Eurocurrency Loan and by up to 125 basis points from 2.75% to 1.50% in the case of any ABR Loan. The Applicable Margin may be reduced by a further 25 basis points in respect of both Eurocurrency Loans and ABR Loans during any period that the Borrower maintains specified public corporate family ratings. Following the amendment, the Term Loan Agreement provides for interest on outstanding principal thereunder at a fluctuating rate, at CPG International LLC’s option, for (i) alternative base rate (“ABR”) borrowings, the highest of (a) the Federal Funds Rate as of such day plus 50 basis points, (b) the prime commercial lending rate announced as of such day by the Administrative Agent as defined in the Term Loan Agreement, as the “prime rate” as in effect on such day and (c) the LIBOR as of such day for a deposit in U.S. dollars with a maturity of one month plus 100 basis points, provided that in no event shall the ABR be less than 175 basis points, plus the applicable margin of 150 basis points per annum; or (ii) for Eurocurrency borrowings, the highest of (a) the LIBOR in effect for such interest period divided by one, minus the statutory reserves applicable to such Eurocurrency borrowing, if any, and (b) 75 basis points, plus the applicable margin of 250 basis points per annum. In connection with the February 2, 2021 amendment, the Company recognized $0.6 million in interest expense in the nine months ended June 30, 2021 related to the write-off of unamortized debt discount and debt issuance costs. The Company incurred $0.1 million in lender fees which, together with $3.6 million in remaining unamortized debt discount and debt issuance costs, have been recorded as a reduction of long-term debt and are being amortized over the remaining contractual life of the Term Loan Agreement using the effective interest method. In addition, the Company also incurred $0.9 million in various third-party fees and expenses related to the amendment to the Term Loan Agreement, which were recorded to interest expense in the nine months ended June 30, 2021. As of June 30, 2021, and September 30, 2020, unamortized deferred financing fees related to the Term Loan Agreement were $2.9 million and $4.2 million, respectively. The Term Loan Agreement may be voluntarily prepaid in whole, or in part, in each case without premium or penalty (other than the Prepayment Premium (as defined in the Term Loan Agreement), if applicable), subject to certain customary conditions. The Term Loan Agreement requires mandatory prepayments of the term loans thereunder from certain debt issuances, certain asset dispositions (subject to certain reinvestment rights) and a percentage of excess cash flow (subject to step-downs upon CPG International LLC achieving certain leverage ratios). At September 30, 2020, no excess cash flow payment was required based on the current leverage ratio. CPG International LLC is required to repay the outstanding principal amount under the Term Loan Agreement in quarterly installments equal to 0.25253% of the aggregate principal amount under the Term Loan Agreement outstanding on the amendment date of June 18, 2018 and such quarterly payments may be reduced as a result of prepayments. Based on prepayments of $337.7 million made during the three months ended June 30, 2020 with the IPO proceeds, CPG International LLC has prepaid all of the quarterly principal payments through maturity. The Company’s next scheduled principal payment on the term loan is due in fiscal year 2024. The Term Loan Agreement restricts payments of dividends unless certain conditions are met, as defined in the Term Loan Agreement. Revolving Credit Facility On September 30, 2013, CPG International LLC (as successor-in-interest to CPG Merger Sub LLC) entered into a revolving credit facility, as amended and restated from time to time (the “Revolving Credit Facility”), with certain lenders party thereto. The Revolving Credit Facility provides for maximum aggregate borrowings of up to $150.0 million, subject to an asset-based borrowing base. The borrowing base is limited to a set percentage of eligible accounts receivable and inventory, less reserves that may be established by the administrative agent and the collateral agent in the exercise of their reasonable credit judgment. CPG International LLC had no outstanding borrowings under the Revolving Credit Facility as of June 30, 2021 and September 30, 2020. In addition, CPG International LLC had $4.4 million and $6.8 million of outstanding letters of credit held against the Revolving Credit Facility as of June 30, 2021 and September 30, 2020, respectively. CPG International LLC had approximately $145.6 million available under the borrowing base for future borrowings as of June 30, 2021. CPG International LLC also has the option to increase the commitments under the Revolving Credit Facility by up to $100.0 million, subject to certain conditions. On March 31, 2021, CPG International LLC amended the Revolving Credit Facility, resulting in a repricing and extension thereof. Pursuant to such amendment, the interest rate has been reduced by 25 basis points to (i) for ABR borrowings, the highest of (a) the Federal Funds Rate plus 50 basis points, (b) the prime rate and (c) the LIBOR as of such date for a deposit in U.S. dollars with a maturity of one month plus 100 basis points, plus, in each case, a spread of 25 to 75 basis points, based on average historical availability, or (ii) for Eurocurrency borrowings, adjusted LIBOR plus a spread of 125 to 175 basis points, based on average historical availability. The maturity date for the Revolving Credit Facility was extended from May 9, 2022 to the earlier of March 31, 2026 and the date that is 91 days prior to the maturity of the Term Loan Agreement or any permitted refinancing thereof. In connection with the March 31, 2021 amendment, the Company recognized $0.1 million in interest expense in the nine months ended June 30, 2021 related to the write-off of unamortized debt issuance costs. The Company incurred $0.9 million in lender and third-party fees which, together with $0.5 million in remaining unamortized debt issuance costs, have been recorded as other assets and are being amortized over the remaining contractual life of the facility on a straight-line basis. A “commitment fee” accrues on any unused portion of the commitments under the Revolving Credit Facility during the preceding three calendar month period. If the average daily used percentage is greater than 50%, the commitment fee equals 25 basis points, and if the average daily used percentage is less than or equal to 50%, the commitment fee equals 37.5 basis points. The commitment fees were $0.1 million and $0.1 million for the three months ended June 30, 2021 and 2020, respectively, and $0.4 million and $0.3 million in the nine months ended June 30, 2021 and 2020, respectively. The obligations under the Revolving Credit Facility are guaranteed by the Company and its wholly owned domestic subsidiaries other than certain immaterial subsidiaries and other excluded subsidiaries. The obligations under the Revolving Credit Facility are secured by a first priority security interest in substantially all of the accounts receivable, inventory, deposit accounts, securities accounts and cash assets of the Company, CPG International LLC and the subsidiaries of CPG International LLC that are guarantors under the Revolving Credit Facility, and the proceeds thereof (subject to certain exceptions) (the “Revolver Priority Collateral”), plus a second priority security interest in all of the Term Loan Priority Collateral. The Revolving Credit Facility may be voluntarily prepaid in whole, or in part, in each case without premium or penalty. CPG International LLC is also required to make mandatory prepayments (i) when aggregate borrowings exceed commitments or the applicable borrowing base and (ii) during “cash dominion,” which occurs if (a) the availability under the Revolving Credit Facility is less than the greater of (i) $12.5 million and (ii) 10% of the lesser of (x) $150.0 million and (y) the borrowing base, for five consecutive business days or (b) certain events of default have occurred and are continuing. The Revolving Credit Facility contains affirmative covenants that are customary for financings of this type, including allowing the Revolver Administrative Agent to perform periodic field exams and appraisals to evaluate the borrowing base. The Revolving Credit Facility contains various negative covenants, including limitations on, subject to certain exceptions, the incurrence of indebtedness, the incurrence of liens, dispositions, investments, acquisitions, restricted payments, transactions with affiliates, as well as other negative covenants customary for financings of this type. The Revolving Credit Facility also includes a financial maintenance covenant, applicable only when the excess availability is less than the greater of (i) 10% of the lesser of the aggregate commitments under the Revolving Credit Facility and the borrowing base, and (ii) $12.5 million . In such circumstances, CPG International LLC would be required to maintain a minimum fixed charge coverage ratio (as defined in the Revolving Credit Facility) for the trailing four quarters equal to at least 1.0 to 1.0 ; subject to CPG International LLC’s ability to make an equity cure (no more than twice in any four quarter period and up to five times over the life of the facility). As of June 30, 2021 , CPG International LLC was in compliance with the financial and nonfinancial covenants imposed by the Revolving Credit Facility. The Revolving Credit Facility also includes customary events of default, including the occurrence of a change of control. 2021 Senior Notes CPG International LLC’s former 8.000% senior notes due October 2021 (the “2021 Senior Notes”) were issued on September 30, 2013, in an aggregate principal amount of $315.0 million, and had a maturity of October 1, 2021. The 2021 Senior Notes bore interest at the rate of 8.000% per annum payable in cash semi-annually in arrears on April 1 and October 1 of each year (computed based on a 360-day year of twelve 30-day months). The obligations under the 2021 Senior Notes were guaranteed by CPG International LLC and those of its subsidiaries that also guarantee the Revolving Credit Facility and the Term Loan Agreement. The redemption price of the 2021 Senior Notes (expressed as percentages of the principal amount to be redeemed) declined to the par value of the 2021 Senior Notes, plus accrued and unpaid interest based on the schedule below. The 2021 Senior Notes were redeemable in whole or in part, at any time after October 1, 2016 at the following redemption prices, if redeemed during the 12-month period beginning on October 1 of the years indicated below: 2016 106.0 % 2017 104.0 % 2018 102.0 % 2019 and thereafter 100.0 % The indenture relating to the 2021 Senior Notes contained negative covenants that are customary for financings of this type. The indenture did not contain any financial maintenance covenants. The Company issued a redemption notice on May 7, 2020 for the full $315.0 million of outstanding 2021 Senior Notes, which were redeemed on June 8, 2020. 2025 Senior Notes On May 12, 2020, CPG International LLC issued $350.0 million of 9.500% 2025 Senior Notes with a maturity of May 15, 2025 (the “2025 Senior Notes”), and interest was payable on May 15 and November 15 of each year. In addition to certain other redemption options, the Company had the option to redeem all of the 2025 Senior Notes with the proceeds from a Qualified IPO at a redemption price equal to 107.125% of the principal amount of the 2025 Senior Notes redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. On June 16, 2020, the Company used part of its net proceeds from the IPO to redeem $350.0 million in aggregate principal of the outstanding 2025 Senior Notes, paid $3.9 million in accrued interest and recognized a $35.6 million loss on the extinguishment in the “Loss on extinguishment of debt” within the Condensed Consolidated Statements of Comprehensive Income (Loss). Interest expense consisted of the following (in thousands): Three Months Ended June 30, Nine Months Ended June 30, 2021 2020 2021 2020 Interest Expense Term Loan Agreement $ 3,842 $ 11,228 $ 13,942 $ 35,584 2021 Senior Notes — 4,550 — 17,150 2025 Senior Notes — 3,879 — 3,879 Revolving Credit Facility 156 846 473 1,434 Other 363 380 1,109 1,155 Amortization - Debt issue costs Term Loan Agreement 254 3,630 2,243 4,620 2021 Senior Notes — 176 — 880 2025 Senior Notes — 180 — 180 Revolving Credit Facility 65 107 429 287 Term Loan OID 30 442 162 562 Capitalized interest (491 ) (270 ) (1,427 ) (849 ) Interest expense $ 4,219 $ 25,148 $ 16,931 $ 64,882 See Note 9 for the fair value of the Company’s debt as of June 30, 2021 and September 30, 2020. |
Product Warranties
Product Warranties | 9 Months Ended |
Jun. 30, 2021 | |
Product Warranties Disclosures [Abstract] | |
Product Warranties | 8. PRODUCT WARRANTIES The Company provides product assurance warranties of various lengths ranging from 5 years to lifetime for limited coverage for a variety of material and workmanship defects based on standard terms and conditions between the Company and its customers. Warranty coverage depends on the product involved. The warranty reserve activity consisted of the following (in thousands): Three Months Ended June 30, Nine Months Ended June 30, 2021 2020 2021 2020 Beginning balance $ 12,065 $ 11,984 $ 10,913 $ 11,133 Adjustments to reserve 1,720 35 4,270 2,226 Warranty claims payment (843 ) (770 ) (2,269 ) (2,247 ) Accretion - purchase accounting valuation — 28 28 165 Ending balance 12,942 11,277 12,942 11,277 Current portion of accrued warranty (2,977 ) (3,375 ) (2,977 ) (3,375 ) Accrued warranty – less current portion $ 9,965 $ 7,902 $ 9,965 $ 7,902 |
Fair Value Of Financial Instrum
Fair Value Of Financial Instruments | 9 Months Ended |
Jun. 30, 2021 | |
Fair Value Disclosures [Abstract] | |
Fair Value Of Financial Instruments | 9. FAIR VALUE OF FINANCIAL INSTRUMENTS FASB Accounting Standards Codification (“ASC”) requirements for Fair Value Measurements and Disclosures establish a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three levels. Level 1 inputs, the highest priority, are quoted prices in active markets for identical assets or liabilities. Level 2 inputs reflect other than quoted prices included in Level 1 that are either observable directly or through corroboration with observable market data. Level 3 inputs are unobservable inputs, due to little or no market activity for the asset or liability, such as internally-developed valuation models. We do not have any assets or liabilities measured at fair value on a recurring basis that are Level 3. The carrying values and the estimated fair values of the debt financial instruments (Level 2 measurements) consisted of the following (in thousands): June 30, 2021 September 30, 2020 Carrying Value Estimated Fair Value Carrying Value Estimated Fair Value Term Loan due May 5, 2024 $ 467,310 $ 466,719 $ 467,147 $ 465,185 |
Segments
Segments | 9 Months Ended |
Jun. 30, 2021 | |
Segment Reporting [Abstract] | |
Segments | 10. SEGMENTS Operating segments for the Company are determined based on information used by the chief operating decision maker (“CODM”) in deciding how to evaluate performance and allocate resources to each of the segments. The CODM reviews Adjusted EBITDA and Adjusted EBITDA Margin as the key segment measures of performance. Adjusted EBITDA is defined as segment operating income (loss) plus depreciation and amortization, adjusted by adding thereto or subtracting therefrom stock-based compensation costs, business transformation costs, acquisition costs, capital structure transaction costs, and certain other costs. Adjusted EBITDA Margin is defined as Adjusted EBITDA divided by net sales. The Company has two reportable segments, Residential and Commercial. The reportable segments were determined primarily based on products and end markets as follows: • Residential—The Residential segment manufactures and distributes decking, rail, trim and accessories through a national network of dealers and distributors and multiple home improvement retailers providing extensive geographic coverage and enabling the Company to effectively serve contractors. The additions of Ultralox and Versatex are complementary to the Residential segment railing and trim businesses, respectively. The recent addition of Return Polymers provides a full-service recycled PVC material processing, sourcing, logistical support, and scrap management programs. This segment is impacted by trends in and the strength of home repair and remodel activity. • Commercial—The Commercial segment manufactures, fabricates and distributes resin based extruded sheeting products for a variety of commercial and industrial applications through a widespread distribution network as well as directly to original equipment manufacturers. This segment includes Scranton Products which manufactures lockers and partitions and Vycom which manufactures resin based sheeting products. This segment is impacted by trends in and the strength of the new construction sector. The segment data below includes data for Residential and Commercial for the three and nine months ended June 30, 2021 and 2020 (in thousands). Three Months Ended June 30, Nine Months Ended June 30, 2021 2020 2021 2020 Net sales to customers Residential $ 291,209 $ 192,599 $ 739,048 $ 538,514 Commercial 36,245 31,112 93,806 96,825 Total $ 327,454 $ 223,711 $ 832,854 $ 635,339 Adjusted EBITDA Residential $ 82,525 $ 62,326 $ 222,999 $ 164,047 Commercial 6,273 5,024 13,304 11,179 Total Adjusted EBITDA for reporting segments $ 88,798 $ 67,350 $ 236,303 $ 175,226 Unallocated net expenses (16,082 ) (9,530 ) (43,623 ) (27,782 ) Adjustments to Income (loss) before income tax provision Depreciation and amortization (25,736 ) (26,597 ) (75,255 ) (75,225 ) Stock-based compensation costs (9,510 ) (18,788 ) (19,646 ) (20,169 ) Business transformation costs (1) — (109 ) — (435 ) Acquisition costs (2) — (182 ) — (1,538 ) Initial public offering costs and Secondary offering costs (1,443 ) (1,623 ) (2,592 ) (6,716 ) Capital structure transaction costs (3) — (37,538 ) — (37,538 ) Other costs (4) (1,228 ) (2,551 ) (3,922 ) (3,015 ) Interest expense, net (4,219 ) (25,148 ) (16,931 ) (64,882 ) Income (loss) before income tax provision $ 30,580 $ (54,716 ) $ 74,334 $ (62,074 ) (1) Business transformation costs reflect consulting and other costs related to the transformation of the senior management team of $0.1 million and $0.4 million for the three and nine months ended June 30, 2020, respectively. (2) Acquisition costs reflect costs directly related to completed acquisitions of $0.1 million and $0.9 million in the three and nine months ended June 30, 2020, respectively, and inventory step-up adjustments related to recording the inventory of acquired businesses at fair value on the date of acquisition of $0.1 million and $0.6 million for the three and nine months ended June 30, 2020, respectively. (3) Capital structure transaction costs include loss on extinguishment of debt of $1.9 million for the 2021 Senior Notes and $35.6 million for the 2025 Senior Notes for the three and nine months ended June 30, 2020. ( 4 ) Other costs include costs for legal expense of $ 0.8 million and $ million for the three months ended June 30, 2021 and 2020 , respectively, and $ 1.8 million and $ 0.4 million for the nine months ended June 30, 2021 and 2020 , respectively , reduction in workforce costs of $ 0.4 million for the three and nine months ended June 30, 2020 and costs related to an incentive plan and other ancillary expenses associated with the initial public offering of $ 0.4 million and $ 1.8 million for the three months ended June 30, 2021 and 2020 , respectively , and $ 2.1 million and $ 2.2 million for the nine months ended June 30, 2021 and 2020 , respectively . |
Capital Stock
Capital Stock | 9 Months Ended |
Jun. 30, 2021 | |
Stockholders Equity Note [Abstract] | |
Capital Stock | 11. CAPITAL STOCK The Company completed its IPO on June 16, 2020, in which it sold 38,237,500 shares of its Class A common stock, including 4,987,500 shares pursuant to the underwriters’ over-allotment option. The shares were sold at an IPO price of $23.00 per share for net proceeds to the Company of approximately $819.7 million, after deducting underwriting discounts and commissions of $50.6 million and offering expenses of approximately $9.2 million payable by the Company. Immediately prior to the completion of the IPO, the Company converted to a Delaware corporation from a limited liability company. The Company’s certificate of incorporation provides for two classes of common stock: Class A common stock and Class B common stock. In addition, the certificate of incorporation authorizes shares of undesignated preferred stock, the rights, preferences and privileges of which may be designated from time to time by the board of directors. The Company is authorized to issue up to 1.1 billion shares of Class A common stock, up to 1 hundred In conjunction with the Corporate Conversion and prior to the closing of the IPO, the Company effected a unit split of its then-outstanding unit, resulting in an aggregate of 108,162,741 units, including 75,093,778 Class A units and 33,068,963 Class B units. Concurrently with the Corporate Conversion, the units were converted to an aggregate of 108,162,741 shares of common stock, including 75,093,778 shares of Class A common stock and 33,068,963 shares of Class B common stock. In addition, a class of the Company’s former indirect parent’s partnership interests referred to as “Profits Interests” were exchanged for an aggregate of 2,703,243 shares of Class A common stock and 5,532,037 shares of Class A restricted stock, and 3,477,413 shares of Class A common stock reserved for issuance upon the exercise of stock options. On September 15, 2020, the Company completed an offering of 28,750,000 shares of Class A common stock, par value $0.001 per share, including the exercise in full by the underwriters of their option to purchase up to 3,750,000 additional shares of Class A common stock, at a public offering price of $33.25 per share. The shares were sold by the Selling Stockholders. The Company did not receive any of the proceeds from the sale of the shares by the Selling Stockholders. Immediately subsequent to the closing of the secondary offering, Class B common stockholders converted 33,068,863 shares of Class B common stock into Class A common stock. On January 26, 2021, the Company completed an offering of 20,000,000 shares of Class A common stock, par value $0.001 per share, including the exercise in full by the underwriters of their option to purchase up to 3,000,000 additional shares of Class A common stock, at a public offering price of $40.00 per share. The shares were sold by certain of the Selling Stockholders. The Company did not receive any of the proceeds from the sale of the shares by those Selling Stockholders. In connection with the offering the Company incurred approximately $1.2 million in expenses. On June 1, 2021, the Company completed an offering of 17,250,000 shares of Class A common stock, par value $0.001 per share, including the exercise in full by the underwriters of their option to purchase up to 2,250,000 additional shares of Class A common stock, at a public offering price of $43.50 per share. The shares were sold by certain of the Selling Stockholders. The Company did not receive any of the proceeds from the sale of the shares by those Selling Stockholders. In connection with the offering the Company incurred approximately $1.1 million in expenses. |
Stock-Based Compensation
Stock-Based Compensation | 9 Months Ended |
Jun. 30, 2021 | |
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] | |
Stock-Based Compensation | 12. STOCK-BASED COMPENSATION The Company grants stock-based awards to attract, retain and motivate key employees and directors. Prior to the completion of the IPO, Profits Interests were issued through an LP Interest Agreement. The Profits Interests were, as part of the Corporate Conversion, converted into shares of common stock, restricted stock and stock options. The 2020 Omnibus Incentive Compensation Plan (“2020 Plan”), became effective as of June 11, 2020, the day of effectiveness of the registration statement filed in connection with the IPO. The 2020 Plan provides for the grant of stock options, stock appreciation rights, restricted stock, restricted stock units, dividend equivalent rights, and performance-based or other equity-related awards to the Company’s employees and directors. The maximum aggregate number of shares that may be issued under the 2020 Plan is 15,852,319 shares with 4,597,638 shares remaining in the reserve. The total aggregate number of shares may be adjusted as determined by the Board of Directors. On February 4, 2021, the Compensation Committee of the Board of Directors authorized certain changes to our Chief Financial Officer’s (“CFO”) stock-based awards which are expected to be effective in connection with his retirement and contingent on the successful transition to his successor. These changes contemplate a retirement eligibility provision which is expected to allow certain awards to continue to vest in due course following retirement and extend the exercisability of the outstanding and exercisable stock options to the end of the contractual term of the options. This resulted in a Type III Modification (improbable to probable) as defined in accounting guidance, accounted for as a cancellation of the original award and a new grant under the revised terms, resulting in $5.1 million and $8.8 million of share-based compensation expense in the three and nine months ended June 30, 2021, respectively, with additional expense being recognized through the required service period. Stock-based compensation expense for the three months ended June 30, 2021 and 2020 was $9.5 million and $18.8 million, respectively, and for the nine months ended June 30, 2021 and 2020 was $19.6 million and $20.2 million, respectively, recognized in “Selling, general and administrative expenses” in the Condensed Consolidated Statements of Comprehensive Income (Loss). Total income tax benefit for the three months ended June 30, 2021 and 2020 was $1.2 million and $1.6 million, respectively, and for the nine months ended June 30, 2021 and 2020 was $2.0 million and $1.6 million, respectively. As of June 30, 2021, the Company had not yet recognized compensation cost on unvested stock-based awards of $25.6 million, with a weighted average remaining recognition period of 2.5 years. The Company uses the Monte Carlo pricing model to estimate the fair value of its performance-based awards as of the grant date, and uses the Black Scholes pricing model to estimate the fair value of its service-based awards as of the grant date. Under the terms of the 2020 Plan, all stock options will expire if not exercised within ten years of the grant date. Stock Options The following table summarizes the performance-based stock option activity for the nine months ended June 30, 2021: Number of Shares Weighted Average Exercise Price Per Share Weighted Average Remaining Contract Term Aggregate Intrinsic Value (in years) (in thousands) Outstanding at October 1, 2020 1,705,498 $ 23.00 Granted — — Exercised (132,705 ) 23.00 Cancelled/Forfeited — — Outstanding at June 30, 2021 1,572,793 23.00 8.9 30,607 Vested and exercisable at June 30, 2021 1,572,793 $ 23.00 8.9 30,607 The following table summarizes the service-based stock option activity for the nine months ended June 30, 2021: Number of Shares Weighted Average Exercise Price Per Share Weighted Average Remaining Contract Term Aggregate Intrinsic Value (in years) (in thousands) Outstanding at October 1, 2020 3,382,947 $ 23.00 Granted 117,989 34.27 Exercised (70,924 ) 23.00 Cancelled/Forfeited (46,437 ) 23.00 Outstanding at June 30, 2021 3,383,575 23.39 9.0 64,515 Vested and exercisable at June 30, 2021 1,585,280 $ 23.00 8.9 30,850 Restricted Stock Awards A summary of the service-based restricted stock awards activity during the nine months ended June 30, 2021 was as follows: Number of Shares Weighted Average Grant Date Fair Value Outstanding and unvested at October 1, 2020 1,485,611 $ 23.00 Granted — — Vested (622,644 ) 23.00 Forfeited (26,394 ) 23.00 Outstanding and unvested at June 30, 2021 836,573 $ 23.00 Performance Restricted Stock Units Performance restricted stock units were granted to officers and certain employees of the Company and represent the right to earn shares of Company common stock based on the achievement of company-wide non-GAAP performance conditions, including cumulative net sales, average return on net tangible assets and cumulative EBITDA during the three-year performance period. Compensation cost is amortized into expense over the performance period, which is generally three years, and is based on the probability of meeting performance targets. The fair value of each performance share award is based on the average of the high and low stock price on the date of grant. A summary of the performance-based restricted stock unit awards activity for the nine months ended June 30, 2021 presented at target was as follows: Number of Shares Weighted Average Grant Date Fair Value Outstanding and unvested at October 1, 2020 — $ — Granted 115,562 34.98 Vested — — Forfeited (2,659 ) 34.27 Outstanding and unvested at June 30, 2021 112,903 $ 34.99 Restricted Stock Units A summary of the service-based restricted stock unit awards activity for the nine months ended June 30, 2021 was as follows: Number of Shares Weighted Average Grant Date Fair Value Outstanding and unvested at October 1, 2020 184,851 $ 23.00 Granted 197,098 35.92 Vested (14,681 ) 29.92 Forfeited (20,519 ) 25.96 Outstanding and unvested at June 30, 2021 346,749 $ 29.89 |
Earnings Per Share
Earnings Per Share | 9 Months Ended |
Jun. 30, 2021 | |
Earnings Per Share [Abstract] | |
Earnings Per Share | 13. EARNINGS PER SHARE The Company computes earnings per common share (“EPS”) under the two-class method which requires the allocation of all distributed and undistributed earnings attributable to the Company to common stock and other participating securities based on their respective rights to receive distributions of earnings or losses. The Company’s Class A common stock and Class B common stock equally share in distributed and undistributed earnings, therefore, no allocation to participating securities or dilutive securities is performed. Basic EPS attributable to common stockholders is calculated by dividing net income (loss) attributable to common stockholders by the weighted-average number of shares of common stock outstanding. Diluted EPS is calculated by adjusting weighted average shares outstanding for the dilutive effect of potential common shares, determined using the treasury-stock method. For purposes of the diluted EPS calculation, restricted stock awards, restricted stock units and options to purchase shares of common stock are considered to be potential common shares. The following table sets forth the computation of the Company’s basic and diluted EPS attributable to common stockholders (in thousands, except share and per share amounts): Three Months Ended June 30, Nine Months Ended June 30, 2021 2020 2021 2020 Numerator: Net income (loss) $ 21,769 $ (52,116 ) $ 54,609 $ (57,874 ) Net income (loss) attributable to common stockholders- basic and diluted $ 21,769 $ (52,116 ) $ 54,609 $ (57,874 ) Denominator: Weighted-average shares of common stock Basic 153,854,313 118,738,357 153,623,579 113,525,537 Diluted 157,022,043 118,738,357 156,658,640 113,525,537 Net income (loss) per share attributable to common stockholders: Net income (loss) per common share - basic $ 0.14 $ (0.44 ) $ 0.36 $ (0.51 ) Net income (loss) per common share - diluted $ 0.14 $ (0.44 ) $ 0.35 $ (0.51 ) The following table includes the number of shares that may be dilutive common shares in the future, and were not included in the computation of diluted net income (loss) per share because the effect was anti-dilutive: Three Months Ended June 30, Nine Months Ended June 30, 2021 2020 2021 2020 Restricted Stock Awards — 1,143,949 — 381,316 Stock Options — 992,632 83,412 330,877 Restricted Stock Units 5,207 32,877 5,160 10,959 |
Income Taxes
Income Taxes | 9 Months Ended |
Jun. 30, 2021 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | 14. INCOME TAXES The Company calculates the interim tax provision in accordance with the provisions of Accounting Standards Codification (“ASC”) 740-270, Income Taxes; Interim Reporting The Company adopted ASU No. 2016-16 , Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory |
Commitments And Contingencies
Commitments And Contingencies | 9 Months Ended |
Jun. 30, 2021 | |
Commitments And Contingencies Disclosure [Abstract] | |
Commitments And Contingencies | 15. COMMITMENTS AND CONTINGENCIES Lease Commitments The Company leases vehicles, machinery and a manufacturing facility under various capital leases. The Company also leases office equipment, vehicles and manufacturing and office facilities under various operating leases. In 2018, the Company entered into a lease agreement for its corporate headquarters in Chicago, IL. The Company was responsible for costs to build out the office space and spent approximately $3.4 million in improvements to meet the Company’s needs. Based on the lease agreement and the changes made to the office space the Company concluded that it was the “deemed owner” of the building (for accounting purposes only) during the construction period. The Company recorded the build out costs as an asset with a corresponding build-to-suit liability while the building was under construction. Upon completion of the improvements to the building, the Company evaluated the derecognition of the asset and liability under the provisions of ASC 840-40, Leases—Sale-Leaseback Transactions During the second quarter of fiscal 2021, the Company signed a fifteen-year Future minimum annual payments under noncancelable leases with initial or remaining noncancelable lease terms in excess of one year as of June 30, 2021 were as follows (in thousands): As of June 30,2021 Capital Financing Operating Remaining period of 2021 $ 428 $ 193 $ 1,035 2022 1,616 787 5,324 2023 1,261 806 5,538 2024 892 826 4,874 2025 648 846 4,441 Thereafter 2,191 3,823 34,892 Total Payments $ 7,036 $ 7,281 $ 56,104 Less amount representing interest (3,319 ) Present value of minimum capital lease payments $ 3,717 Total rent expense was approximately $1.0 million and $0.4 million for the three months ended June 30, 2021 and 2020, respectively, and $2.4 million and $1.1 million for the nine months ended June 30, 2021 and 2020, respectively. The future minimum sublease income under a noncancelable subleases was $0.7 million at June 30, 2021. Legal Proceedings In the normal course of the Company’s business, it is at times subject to pending and threatened legal actions, in some cases for which the relief or damages sought may be substantial. Although the Company is not able to predict the outcome of such actions, after reviewing all pending and threatened actions with counsel and based on information currently available, management believes that the outcome of such actions, individually or in the aggregate, will not have a material adverse effect on the Company’s results of operations or financial position. However, it is possible that the ultimate resolution of such matters, if unfavorable, may be material to the Company’s results of operations in a particular future period as the time and amount of any resolution of such actions and its relationship to the future results of operations are not currently known. The Company accrues for losses when they are probable of occurrence and such losses are reasonably estimable. Legal costs expected to be incurred are accounted for as they are incurred. Loss Contingencies During the year ended September 30, 2019, the Company was made aware of a worker’s compensation case that became reasonably possible to give rise to a liability. The case remains in discovery, and the nature and extent of the Company’s exposure is being determined. The Company expects a range of loss of $0.4 million to $0.5 million. As of June 30, 2021, there are various other worker’s compensation and personal injury claims that have been made against the Company. All such claims are being contested and the Company does not believe a loss is probable; therefore, no reserve has been recorded related to these matters. In addition, the Company carries insurance for these types of matters and is expecting to recover thereon. The Company is a party to various legal proceedings and claims, which arise in the ordinary course of business. As of June 30, 2021, the Company determined that there was not at least a reasonable possibility that it had incurred a material loss, or a material loss in excess of a recorded accrual, with respect to such proceedings. |
Condensed Financial Information
Condensed Financial Information of Registrant (Parent Company Only) | 9 Months Ended |
Jun. 30, 2021 | |
Condensed Financial Information Of Parent Company Only Disclosure [Abstract] | |
Condensed Financial Information of Registrant (Parent Company Only) | 16. CONDENSED FINANCIAL INFORMATION OF REGISTRANT (PARENT COMPANY ONLY) The AZEK Company Inc. (parent company only) Balance Sheets (In thousands of U.S. dollars, except for share and per share amounts) June 30, 2021 September 30, 2020 ASSETS: Non-current assets: Investments in subsidiaries $ 1,382,173 $ 1,303,888 Total non-current assets 1,382,173 1,303,888 Total assets $ 1,382,173 $ 1,303,888 LIABILITIES AND STOCKHOLDERS’ EQUITY: Total liabilities $ — $ — Stockholders’ equity: Preferred stock, $0.001 par value; 1,000,000 shares authorized and no shares issued and outstanding at June 30, 2021 and at September 30, 2020, respectively — — Class A common stock, $0.001 par value; 1,100,000,000 shares authorized, 154,829,153 shares issued and outstanding at June 30, 2021 and 154,637,240 shares issued and outstanding at September 30, 2020 155 155 Class B common stock, $0.001 par value; 100,000,000 shares authorized, 100 shares issued and outstanding at June 30, 2021 and at September 30, 2020, respectively — — Additional paid-in capital 1,610,884 1,587,208 Accumulated deficit (228,866 ) (283,475 ) Total stockholders’ equity 1,382,173 1,303,888 Total liabilities and stockholders’ equity $ 1,382,173 $ 1,303,888 Three Months Ended June 30, Nine Months Ended June 30, 2021 2020 2021 2020 Net income (loss) of subsidiaries $ 21,769 $ (52,116 ) $ 54,609 $ (57,874 ) Net income (loss) of subsidiaries $ 21,769 $ (52,116 ) $ 54,609 $ (57,874 ) Comprehensive income (loss) $ 21,769 $ (52,116 ) $ 54,609 $ (57,874 ) The AZEK Company Inc. did not have any cash as of June 30, 2021 or September 30, 2020, accordingly a Condensed Statement of Cash Flows has not been presented. Basis of Presentation The parent company financial statements should be read in conjunction with the Company’s Consolidated Financial Statements and the accompanying notes thereto. For purposes of this condensed financial information, the Company’s wholly owned and majority owned subsidiaries are recorded based upon its proportionate share of the subsidiaries’ net assets (similar to presenting them on the equity method). Since the restricted net assets of The AZEK Company Inc. and its subsidiaries exceed 25% of the consolidated net assets of the Company and its subsidiaries, the accompanying condensed parent company financial statements have been prepared in accordance with Rule 12-04, Schedule 1 of Regulation S-X. This information should be read in conjunction with the accompanying Consolidated Financial Statements. Dividends from Subsidiaries There were no cash dividends paid to The AZEK Company Inc. from the Company’s consolidated subsidiaries during each of the three and nine months ended June 30, 2021 and 2020. Restricted Payments CPG International LLC is party to the Revolving Credit Facility and the Term Loan Agreement originally executed on September 30, 2013, both of which have been amended and extended from time to time. The obligations under the Revolving Credit Facility and Term Loan Agreement are secured by substantially all of the present and future assets of the borrowers and guarantors, including equity interests of their domestic subsidiaries, subject to certain exceptions. The obligations under the Revolving Credit Facility and Term Loan Agreement are guaranteed by the Company and its wholly owned domestic subsidiaries other than certain immaterial subsidiaries and other excluded subsidiaries. CPG International LLC is not permitted to make certain payments unless those payments are consistent with exceptions outlined in the agreements. These payments include repurchase of equity interests, fees associated with a public offering, income taxes due in other applicable payments. Further, the payments are only permitted if certain conditions are met related to availability and fixed charge coverage as defined in the Revolving Credit Facility and described in Note 7 to these Consolidated Financial Statements. |
Organization and Summary of S_2
Organization and Summary of Significant Accounting Policies (Policies) | 9 Months Ended |
Jun. 30, 2021 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation The Company operates on a fiscal year ending September 30. The accompanying unaudited Condensed Consolidated Financial Statements and notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information, and in management’s opinion, includes all adjustments, consisting of only normal recurring adjustments, necessary for the fair statement of the Company’s financial position, its results of operations and cash flows for the interim periods presented. The results of operations for the three and nine months ended June 30, 2021 and the cash flows for the nine months ended June 30, 2021 are not necessarily indicative of the results to be expected for the full fiscal year or any other period. The Company’s financial condition and results of operations are being, and are expected to continue to be affected by the current COVID-19 public health pandemic. The economic effects of the COVID-19 pandemic will likely continue to affect demand for the Company’s products in the foreseeable future. Although management has implemented measures to mitigate any impact of the COVID-19 pandemic on the Company’s business, financial condition and results of operations, these measures may not fully mitigate the impact of the COVID-19 pandemic on the Company’s business, financial condition and results of operations. Management cannot predict the degree to, or the period over, which the Company will be affected by the COVID-19 pandemic and resulting governmental and other measures. The accompanying unaudited Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and notes thereto included in the Company’s 2020 Form 10-K. The Condensed Consolidated Balance Sheet as of September 30, 2020 was derived from the audited financial statements at that date. There have been no material changes in the Company’s significant accounting policies from those that were disclosed in the 2020 Form 10-K, except as noted below. |
Use of Estimates | Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Significant estimates include revenue recognition, reserves for excess inventory, inventory obsolescence, product warranties, customer rebates, stock-based compensation, litigation, income taxes, contingent consideration, goodwill and intangible asset valuation and accounting for long-lived assets. Management’s estimates and assumptions are evaluated on an ongoing basis and are based on historical experience, current conditions and available information. Actual results may differ from estimated amounts. Estimates are revised as additional information becomes available. |
Accounting Policies | Accounting Policies Refer to the Company’s 2020 Form 10-K for a discussion of the Company’s accounting policies, as updated below and for recently adopted accounting standards. |
Research and Development Costs | Research and Development Costs Research and development costs primarily relate to new product development, product claims support and manufacturing process improvements. Such costs are expensed as incurred and are included in “Selling, general and administrative expenses” within the Condensed Consolidated Statements of Comprehensive Income (Loss). Total research and development expenses were approximately $1.9 million and $1.7 million, respectively, for the three months ended June 30, 2021 and 2020, and approximately $5.5 million and $5.7 million, respectively, for the nine months ended June 30, 2021 and 2020. |
Recently Issued Accounting Pronouncements | Recently Adopted Accounting Pronouncements Under the Jumpstart Our Business Startups (“JOBS”) Act, the Company qualifies as an emerging growth company (“EGC”) and as such, has elected not to opt out of the extended transition period for complying with new or revised accounting pronouncements. During the extended transition period, the Company is not subject to new or revised accounting standards applicable to public companies. The accounting pronouncements pending adoption below reflect effective dates for the Company as an EGC with the extended transition period. Based on our public float calculation at March 31, 2021, the Company will be deemed a Large Accelerated Filer under the U.S. Securities and Exchange Commission guidelines and will cease to qualify as an EGC effective September 30, 2021. The loss of EGC status will result in losing the reporting exemptions noted above, and in particular will require our independent registered public accounting firm to provide an attestation report on the effectiveness of our internal control over financial reporting as of and for the year ended September 30, 2021 under Section 404(b) of the Sarbanes-Oxley Act. On October 1, 2019, the Company adopted ASU No. 2016-16, Income Taxes (Topic 740): Intra-Entity Transfer of Assets Other Than Inventory On October 1, 2020, the Company adopted ASU No. 2018-13, Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement, Fair Value Measurement Recently Issued Accounting Pronouncements In February 2016, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2016-02, Leases (Topic 842), In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments—Credit Losses (Topic 326) In August 2018, the FASB issued ASU No. 2018-15, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740)—Simplifying the Accounting for Income Taxes of the amendments is permitted, including adoption in any interim period for (1) public business entities for periods for which financial statements have not yet been issued and (2) all other entities for periods for which financial statements have not yet been made available for issuance. An entity that elects to early adopt the amendments in an interim period should reflect any adjustments as of the beginning of the annual period that includes that interim period. Additionally, an entity that elects early adoption must adopt all the amendments in the same period. The amendments are applied on a prospective or retrospective basis, depending upon the amendment adopted within this ASU. The amendments in this ASU are effective for the Company for annual period s ending September 30, 2021 and thereafter and interim periods within annual periods beginning October 1, 2021 . The Company is currently evaluating the impact this adoption will have on its Consolidated Financial Statements. In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting |
Revenue (Tables)
Revenue (Tables) | 9 Months Ended |
Jun. 30, 2021 | |
Revenue From Contract With Customer [Abstract] | |
Summary of Rebate Activity | The rebate activity was as follows (in thousands): Three Months Ended June 30, Nine Months Ended June 30, 2021 2020 2021 2020 Beginning balance $ 27,791 $ 22,123 $ 32,679 $ 24,858 Rebate expense 20,645 11,545 54,857 44,989 Rebate payments (12,257 ) (7,844 ) (51,357 ) (44,023 ) Ending balance $ 36,179 $ 25,824 $ 36,179 $ 25,824 |
Inventories (Tables)
Inventories (Tables) | 9 Months Ended |
Jun. 30, 2021 | |
Inventory Disclosure [Abstract] | |
Schedule of Inventories | Inventories consisted of the following (in thousands): in thousands June 30, 2021 September 30, 2020 Raw materials $ 39,417 $ 33,850 Work in process 24,371 19,935 Finished goods 109,003 76,285 Total inventories $ 172,791 $ 130,070 |
Property, Plant and Equipment_2
Property, Plant and Equipment - Net (Tables) | 9 Months Ended |
Jun. 30, 2021 | |
Property Plant And Equipment [Abstract] | |
Summary of Property, Plant and Equipment - Net | Property, plant and equipment – net consisted of the following (in thousands): June 30, 2021 September 30, 2020 Land and improvements $ 2,758 $ 2,758 Buildings and improvements 77,083 71,059 Capital lease – building 2,021 2,021 Capital lease – manufacturing equipment 1,026 1,026 Capital lease – vehicles 4,050 3,782 Manufacturing equipment 389,503 306,036 Computer equipment 27,301 24,927 Furniture and fixtures 6,013 5,689 Vehicles 588 465 Total property and equipment 510,343 417,763 Construction in progress 77,705 54,412 588,048 472,175 Accumulated depreciation (246,363 ) (210,401 ) Total property and equipment – net $ 341,685 $ 261,774 |
Goodwill and Intangible Asset_2
Goodwill and Intangible Assets - Net (Tables) | 9 Months Ended |
Jun. 30, 2021 | |
Goodwill And Intangible Assets Disclosure [Abstract] | |
Summary of Finite-lived Intangible Assets | Finite-lived intangible assets consisted of the following (in thousands): June 30, 2021 Lives in Years Gross Carrying Value Accumulated Amortization Net Carrying Value Proprietary knowledge 10 - 15 $ 289,300 $ (211,114 ) $ 78,186 Trademarks 5 - 20 223,840 (135,904 ) 87,936 Customer relationships 15 - 19 146,670 (61,434 ) 85,236 Patents 10 7,000 (3,882 ) 3,118 Other intangibles 3 - 15 4,076 (3,844 ) 232 Total intangible assets $ 670,886 $ (416,178 ) $ 254,708 September 30, 2020 Lives in Years Gross Carrying Value Accumulated Amortization Net Carrying Value Propriety knowledge 10 — 15 $ 289,300 $ (195,303 ) $ 93,997 Trademarks 5 — 20 223,840 (124,521 ) 99,319 Customer relationships 15 — 19 146,670 (52,119 ) 94,551 Patents 10 7,000 (3,182 ) 3,818 Other intangible assets 3 — 15 4,076 (3,387 ) 689 Total intangible assets $ 670,886 $ (378,512 ) $ 292,374 |
Composition of Certain Balanc_2
Composition of Certain Balance Sheet Accounts (Tables) | 9 Months Ended |
Jun. 30, 2021 | |
Composition Of Certain Balance Sheet Accounts Disclosure [Abstract] | |
Summary of Allowance for Doubtful Accounts | Allowance for doubtful accounts consisted of the following (in thousands): Three Months Ended June 30, Nine Months Ended June 30, 2021 2020 2021 2020 Beginning balance $ 1,487 $ 1,678 $ 1,332 $ 904 Provision 116 (229 ) 271 522 Bad debt write-offs (540 ) (107 ) (540 ) (119 ) Acquisition — — — 35 Ending balance $ 1,063 $ 1,342 $ 1,063 $ 1,342 |
Schedule of Accrued Expenses and Other Liabilities | Accrued expenses consisted of the following (in thousands): June 30, 2021 September 30, 2020 Employee related liabilities $ 30,949 $ 26,554 Freight 3,277 5,530 Professional fees 4,030 4,249 Marketing 3,491 3,343 Warranty 2,977 2,921 Construction in progress 2,250 1,303 Capital lease 1,064 969 Manufacturing related accruals 1,816 1,664 Other 4,056 3,983 Ending balance $ 53,910 $ 50,516 |
Debt (Tables)
Debt (Tables) | 9 Months Ended |
Jun. 30, 2021 | |
Debt Instrument [Line Items] | |
Summary of Long-term Debt | Debt consisted of the following (in thousands): June 30, 2021 September 30, 2020 Term Loan due May 5, 2024 — LIBOR + 2.50% (3.25% at June 30, 2021) and LIBOR + 3.75% (4.75% at September 30, 2020), (includes a discount of $344 and $507 at June 30, 2021 and September 30, 2020, respectively) $ 467,310 $ 467,147 Revolving Credit Facility through March 31, 2026 - LIBOR + 1.25% at June 30, 2021 and LIBOR +2.00% at September 30, 2020 — — Senior Notes due October 1, 2021 — Fixed at 8% — — Total 467,310 467,147 Less unamortized deferred financing costs (2,879 ) (4,165 ) Less current portion — — Long-term debt—less current portion and unamortized deferred financing costs $ 464,431 $ 462,982 |
Summary of Interest Expense | Interest expense consisted of the following (in thousands): Three Months Ended June 30, Nine Months Ended June 30, 2021 2020 2021 2020 Interest Expense Term Loan Agreement $ 3,842 $ 11,228 $ 13,942 $ 35,584 2021 Senior Notes — 4,550 — 17,150 2025 Senior Notes — 3,879 — 3,879 Revolving Credit Facility 156 846 473 1,434 Other 363 380 1,109 1,155 Amortization - Debt issue costs Term Loan Agreement 254 3,630 2,243 4,620 2021 Senior Notes — 176 — 880 2025 Senior Notes — 180 — 180 Revolving Credit Facility 65 107 429 287 Term Loan OID 30 442 162 562 Capitalized interest (491 ) (270 ) (1,427 ) (849 ) Interest expense $ 4,219 $ 25,148 $ 16,931 $ 64,882 |
2021 Senior Notes [Member] | |
Debt Instrument [Line Items] | |
Summary of Debt Instrument Redemption | The 2021 Senior Notes were redeemable in whole or in part, at any time after October 1, 2016 at the following redemption prices, if redeemed during the 12-month period beginning on October 1 of the years indicated below: 2016 106.0 % 2017 104.0 % 2018 102.0 % 2019 and thereafter 100.0 % |
Product Warranties (Tables)
Product Warranties (Tables) | 9 Months Ended |
Jun. 30, 2021 | |
Product Warranties Disclosures [Abstract] | |
Summary of Warranty Reserve Activity | Warranty coverage depends on the product involved. The warranty reserve activity consisted of the following (in thousands): Three Months Ended June 30, Nine Months Ended June 30, 2021 2020 2021 2020 Beginning balance $ 12,065 $ 11,984 $ 10,913 $ 11,133 Adjustments to reserve 1,720 35 4,270 2,226 Warranty claims payment (843 ) (770 ) (2,269 ) (2,247 ) Accretion - purchase accounting valuation — 28 28 165 Ending balance 12,942 11,277 12,942 11,277 Current portion of accrued warranty (2,977 ) (3,375 ) (2,977 ) (3,375 ) Accrued warranty – less current portion $ 9,965 $ 7,902 $ 9,965 $ 7,902 |
Fair Value Of Financial Instr_2
Fair Value Of Financial Instruments (Tables) | 9 Months Ended |
Jun. 30, 2021 | |
Fair Value Disclosures [Abstract] | |
Summary of Carrying Values and the Estimated Fair Values of the Debt Financial Instruments | The carrying values and the estimated fair values of the debt financial instruments (Level 2 measurements) consisted of the following (in thousands): June 30, 2021 September 30, 2020 Carrying Value Estimated Fair Value Carrying Value Estimated Fair Value Term Loan due May 5, 2024 $ 467,310 $ 466,719 $ 467,147 $ 465,185 |
Segments (Tables)
Segments (Tables) | 9 Months Ended |
Jun. 30, 2021 | |
Segment Reporting [Abstract] | |
Summary of Residential and Commercial Segment Reporting Information | The segment data below includes data for Residential and Commercial for the three and nine months ended June 30, 2021 and 2020 (in thousands). Three Months Ended June 30, Nine Months Ended June 30, 2021 2020 2021 2020 Net sales to customers Residential $ 291,209 $ 192,599 $ 739,048 $ 538,514 Commercial 36,245 31,112 93,806 96,825 Total $ 327,454 $ 223,711 $ 832,854 $ 635,339 Adjusted EBITDA Residential $ 82,525 $ 62,326 $ 222,999 $ 164,047 Commercial 6,273 5,024 13,304 11,179 Total Adjusted EBITDA for reporting segments $ 88,798 $ 67,350 $ 236,303 $ 175,226 Unallocated net expenses (16,082 ) (9,530 ) (43,623 ) (27,782 ) Adjustments to Income (loss) before income tax provision Depreciation and amortization (25,736 ) (26,597 ) (75,255 ) (75,225 ) Stock-based compensation costs (9,510 ) (18,788 ) (19,646 ) (20,169 ) Business transformation costs (1) — (109 ) — (435 ) Acquisition costs (2) — (182 ) — (1,538 ) Initial public offering costs and Secondary offering costs (1,443 ) (1,623 ) (2,592 ) (6,716 ) Capital structure transaction costs (3) — (37,538 ) — (37,538 ) Other costs (4) (1,228 ) (2,551 ) (3,922 ) (3,015 ) Interest expense, net (4,219 ) (25,148 ) (16,931 ) (64,882 ) Income (loss) before income tax provision $ 30,580 $ (54,716 ) $ 74,334 $ (62,074 ) (1) Business transformation costs reflect consulting and other costs related to the transformation of the senior management team of $0.1 million and $0.4 million for the three and nine months ended June 30, 2020, respectively. (2) Acquisition costs reflect costs directly related to completed acquisitions of $0.1 million and $0.9 million in the three and nine months ended June 30, 2020, respectively, and inventory step-up adjustments related to recording the inventory of acquired businesses at fair value on the date of acquisition of $0.1 million and $0.6 million for the three and nine months ended June 30, 2020, respectively. (3) Capital structure transaction costs include loss on extinguishment of debt of $1.9 million for the 2021 Senior Notes and $35.6 million for the 2025 Senior Notes for the three and nine months ended June 30, 2020. ( 4 ) Other costs include costs for legal expense of $ 0.8 million and $ million for the three months ended June 30, 2021 and 2020 , respectively, and $ 1.8 million and $ 0.4 million for the nine months ended June 30, 2021 and 2020 , respectively , reduction in workforce costs of $ 0.4 million for the three and nine months ended June 30, 2020 and costs related to an incentive plan and other ancillary expenses associated with the initial public offering of $ 0.4 million and $ 1.8 million for the three months ended June 30, 2021 and 2020 , respectively , and $ 2.1 million and $ 2.2 million for the nine months ended June 30, 2021 and 2020 , respectively . |
Stock-Based Compensation (Table
Stock-Based Compensation (Tables) | 9 Months Ended |
Jun. 30, 2021 | |
Performance Shares [Member] | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Summary of Share-Based Compensation Stock Options Activity | The following table summarizes the performance-based stock option activity for the nine months ended June 30, 2021: Number of Shares Weighted Average Exercise Price Per Share Weighted Average Remaining Contract Term Aggregate Intrinsic Value (in years) (in thousands) Outstanding at October 1, 2020 1,705,498 $ 23.00 Granted — — Exercised (132,705 ) 23.00 Cancelled/Forfeited — — Outstanding at June 30, 2021 1,572,793 23.00 8.9 30,607 Vested and exercisable at June 30, 2021 1,572,793 $ 23.00 8.9 30,607 |
Service Based Stock Option Activity [Member] | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Summary of Share-Based Compensation Stock Options Activity | The following table summarizes the service-based stock option activity for the nine months ended June 30, 2021: Number of Shares Weighted Average Exercise Price Per Share Weighted Average Remaining Contract Term Aggregate Intrinsic Value (in years) (in thousands) Outstanding at October 1, 2020 3,382,947 $ 23.00 Granted 117,989 34.27 Exercised (70,924 ) 23.00 Cancelled/Forfeited (46,437 ) 23.00 Outstanding at June 30, 2021 3,383,575 23.39 9.0 64,515 Vested and exercisable at June 30, 2021 1,585,280 $ 23.00 8.9 30,850 |
Service Based Restricted Stock [Member] | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Summary of Non-Vested Restricted Stock Activity | A summary of the service-based restricted stock awards activity during the nine months ended June 30, 2021 was as follows: Number of Shares Weighted Average Grant Date Fair Value Outstanding and unvested at October 1, 2020 1,485,611 $ 23.00 Granted — — Vested (622,644 ) 23.00 Forfeited (26,394 ) 23.00 Outstanding and unvested at June 30, 2021 836,573 $ 23.00 |
Schedule of Unvested Restricted Stock Units | A summary of the service-based restricted stock unit awards activity for the nine months ended June 30, 2021 was as follows: Number of Shares Weighted Average Grant Date Fair Value Outstanding and unvested at October 1, 2020 184,851 $ 23.00 Granted 197,098 35.92 Vested (14,681 ) 29.92 Forfeited (20,519 ) 25.96 Outstanding and unvested at June 30, 2021 346,749 $ 29.89 |
Performance Based Restricted Stock [Member] | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Summary of Non-Vested Restricted Stock Activity | A summary of the performance-based restricted stock unit awards activity for the nine months ended June 30, 2021 presented at target was as follows: Number of Shares Weighted Average Grant Date Fair Value Outstanding and unvested at October 1, 2020 — $ — Granted 115,562 34.98 Vested — — Forfeited (2,659 ) 34.27 Outstanding and unvested at June 30, 2021 112,903 $ 34.99 |
Earnings Per Share (Tables)
Earnings Per Share (Tables) | 9 Months Ended |
Jun. 30, 2021 | |
Earnings Per Share [Abstract] | |
Summary of Computation of Basic And Diluted Earnings Per Share | The following table sets forth the computation of the Company’s basic and diluted EPS attributable to common stockholders (in thousands, except share and per share amounts): Three Months Ended June 30, Nine Months Ended June 30, 2021 2020 2021 2020 Numerator: Net income (loss) $ 21,769 $ (52,116 ) $ 54,609 $ (57,874 ) Net income (loss) attributable to common stockholders- basic and diluted $ 21,769 $ (52,116 ) $ 54,609 $ (57,874 ) Denominator: Weighted-average shares of common stock Basic 153,854,313 118,738,357 153,623,579 113,525,537 Diluted 157,022,043 118,738,357 156,658,640 113,525,537 Net income (loss) per share attributable to common stockholders: Net income (loss) per common share - basic $ 0.14 $ (0.44 ) $ 0.36 $ (0.51 ) Net income (loss) per common share - diluted $ 0.14 $ (0.44 ) $ 0.35 $ (0.51 ) |
Summary of Antidilutive Securities Excluded From Computation of Earnings Per Share | The following table includes the number of shares that may be dilutive common shares in the future, and were not included in the computation of diluted net income (loss) per share because the effect was anti-dilutive: Three Months Ended June 30, Nine Months Ended June 30, 2021 2020 2021 2020 Restricted Stock Awards — 1,143,949 — 381,316 Stock Options — 992,632 83,412 330,877 Restricted Stock Units 5,207 32,877 5,160 10,959 |
Commitments And Contingencies (
Commitments And Contingencies (Tables) | 9 Months Ended |
Jun. 30, 2021 | |
Commitments And Contingencies Disclosure [Abstract] | |
Summary of Future Minimum Annual Payments Under Noncancelable Leases | Future minimum annual payments under noncancelable leases with initial or remaining noncancelable lease terms in excess of one year as of June 30, 2021 were as follows (in thousands): As of June 30,2021 Capital Financing Operating Remaining period of 2021 $ 428 $ 193 $ 1,035 2022 1,616 787 5,324 2023 1,261 806 5,538 2024 892 826 4,874 2025 648 846 4,441 Thereafter 2,191 3,823 34,892 Total Payments $ 7,036 $ 7,281 $ 56,104 Less amount representing interest (3,319 ) Present value of minimum capital lease payments $ 3,717 |
Condensed Financial Informati_2
Condensed Financial Information of Registrant (Parent Company Only) (Tables) - Parent Company [Member] | 9 Months Ended |
Jun. 30, 2021 | |
Schedule of Balance Sheets | The AZEK Company Inc. (parent company only) Balance Sheets (In thousands of U.S. dollars, except for share and per share amounts) June 30, 2021 September 30, 2020 ASSETS: Non-current assets: Investments in subsidiaries $ 1,382,173 $ 1,303,888 Total non-current assets 1,382,173 1,303,888 Total assets $ 1,382,173 $ 1,303,888 LIABILITIES AND STOCKHOLDERS’ EQUITY: Total liabilities $ — $ — Stockholders’ equity: Preferred stock, $0.001 par value; 1,000,000 shares authorized and no shares issued and outstanding at June 30, 2021 and at September 30, 2020, respectively — — Class A common stock, $0.001 par value; 1,100,000,000 shares authorized, 154,829,153 shares issued and outstanding at June 30, 2021 and 154,637,240 shares issued and outstanding at September 30, 2020 155 155 Class B common stock, $0.001 par value; 100,000,000 shares authorized, 100 shares issued and outstanding at June 30, 2021 and at September 30, 2020, respectively — — Additional paid-in capital 1,610,884 1,587,208 Accumulated deficit (228,866 ) (283,475 ) Total stockholders’ equity 1,382,173 1,303,888 Total liabilities and stockholders’ equity $ 1,382,173 $ 1,303,888 |
Schedule of Statements of Comprehensive Income (Loss) | Three Months Ended June 30, Nine Months Ended June 30, 2021 2020 2021 2020 Net income (loss) of subsidiaries $ 21,769 $ (52,116 ) $ 54,609 $ (57,874 ) Net income (loss) of subsidiaries $ 21,769 $ (52,116 ) $ 54,609 $ (57,874 ) Comprehensive income (loss) $ 21,769 $ (52,116 ) $ 54,609 $ (57,874 ) |
Organization and Summary of S_3
Organization and Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands | Jun. 01, 2021 | Jan. 26, 2021 | Sep. 15, 2020 | Jun. 16, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | Sep. 30, 2020 | Oct. 01, 2019 |
Organization And Summary Of Significant Accounting Policies [Line Items] | ||||||||||
Proceeds from issuance initial public offering | $ 819,700 | $ (210) | $ 822,630 | |||||||
Underwriting discounts and commissions payments | 50,600 | |||||||||
Estimated offering expenses payable | 9,200 | |||||||||
Prepayment of senior notes | 665,000 | |||||||||
Research and development expenses | $ 1,900 | $ 1,700 | 5,500 | $ 5,700 | ||||||
Retained earnings | $ (228,866) | $ (228,866) | $ (283,475) | |||||||
Revision of Prior Period, Adjustment [Member] | Adoption of ASU [Member] | ||||||||||
Organization And Summary Of Significant Accounting Policies [Line Items] | ||||||||||
Retained earnings | $ 1,300 | |||||||||
Common Class A [Member] | ||||||||||
Organization And Summary Of Significant Accounting Policies [Line Items] | ||||||||||
Shares issued during period | 38,237,500 | 38,237,500 | ||||||||
Common stock, par value per share | $ 0.001 | $ 0.001 | $ 0.001 | |||||||
Common Class B [Member] | ||||||||||
Organization And Summary Of Significant Accounting Policies [Line Items] | ||||||||||
Common stock, par value per share | $ 0.001 | $ 0.001 | $ 0.001 | |||||||
Conversion of Class B common stock into Class A common stock (in shares) | 33,068,863 | |||||||||
Revolving Credit Facility [Member] | ||||||||||
Organization And Summary Of Significant Accounting Policies [Line Items] | ||||||||||
Revolving Credit Facility, outstanding amount | 70,000 | $ 4,400 | $ 4,400 | $ 6,800 | ||||||
2020 Senior Notes [Member] | ||||||||||
Organization And Summary Of Significant Accounting Policies [Line Items] | ||||||||||
Senior notes outstanding | 350,000 | |||||||||
Prepayment of senior notes | $ 337,700 | |||||||||
IPO [Member] | ||||||||||
Organization And Summary Of Significant Accounting Policies [Line Items] | ||||||||||
Shares issued during period | 38,237,500 | |||||||||
Shares issued price | $ 23 | |||||||||
IPO [Member] | Common Class A [Member] | ||||||||||
Organization And Summary Of Significant Accounting Policies [Line Items] | ||||||||||
Shares issued during period | 38,237,500 | |||||||||
Over-Allotment Option [Member] | ||||||||||
Organization And Summary Of Significant Accounting Policies [Line Items] | ||||||||||
Shares issued during period | 4,987,500 | |||||||||
Over-Allotment Option [Member] | Common Class A [Member] | ||||||||||
Organization And Summary Of Significant Accounting Policies [Line Items] | ||||||||||
Shares issued price | $ 43.50 | $ 40 | $ 33.25 | |||||||
Overallotment stock shares sold by shareholders during the period | 2,250,000 | 3,000,000 | 3,750,000 | |||||||
Secondary Offerings Member [Member] | Common Class A [Member] | ||||||||||
Organization And Summary Of Significant Accounting Policies [Line Items] | ||||||||||
Stock shares sold by shareholders during the period | 17,250,000 | 20,000,000 | 28,750,000 | |||||||
Common stock, par value per share | $ 0.001 | $ 0.001 | $ 0.001 | |||||||
Estimated offering expenses | $ 1,100 | $ 1,200 |
Revenue - Additional Informatio
Revenue - Additional Information (Detail) - USD ($) $ in Thousands | Jun. 30, 2021 | Sep. 30, 2020 | Jun. 30, 2020 |
Revenue From Contract With Customer [Abstract] | |||
Accrued rebates | $ 32,820 | $ 30,362 | $ 22,800 |
Contra trade receivable | $ 3,400 | $ 3,000 |
Revenue - Summary of Rebate Act
Revenue - Summary of Rebate Activity (Detail) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | |
Revenue From Contract With Customer [Abstract] | ||||
Beginning balance | $ 27,791 | $ 22,123 | $ 32,679 | $ 24,858 |
Rebate expense | 20,645 | 11,545 | 54,857 | 44,989 |
Rebate payments | (12,257) | (7,844) | (51,357) | (44,023) |
Ending balance | $ 36,179 | $ 25,824 | $ 36,179 | $ 25,824 |
Inventories - Schedule of Inven
Inventories - Schedule of Inventories (Detail) - USD ($) $ in Thousands | Jun. 30, 2021 | Sep. 30, 2020 |
Inventory Disclosure [Abstract] | ||
Raw materials | $ 39,417 | $ 33,850 |
Work in process | 24,371 | 19,935 |
Finished goods | 109,003 | 76,285 |
Total inventories | $ 172,791 | $ 130,070 |
Property, Plant and Equipment_3
Property, Plant and Equipment - Net - Summary of Property, Plant and Equipment - Net (Detail) - USD ($) $ in Thousands | Jun. 30, 2021 | Sep. 30, 2020 |
Property Plant And Equipment [Line Items] | ||
Property and Equipment Excluding Construction in Progress Gross | $ 510,343 | $ 417,763 |
Property and Equipment, Gross | 588,048 | 472,175 |
Accumulated depreciation | (246,363) | (210,401) |
Total property and equipment – net | 341,685 | 261,774 |
Land and Improvements [Member] | ||
Property Plant And Equipment [Line Items] | ||
Property and Equipment Excluding Construction in Progress Gross | 2,758 | 2,758 |
Buildings and Improvements [Member] | ||
Property Plant And Equipment [Line Items] | ||
Property and Equipment Excluding Construction in Progress Gross | 77,083 | 71,059 |
Capital Lease - Building [Member] | ||
Property Plant And Equipment [Line Items] | ||
Property and Equipment Excluding Construction in Progress Gross | 2,021 | 2,021 |
Capital Lease - Manufacturing Equipment [Member] | ||
Property Plant And Equipment [Line Items] | ||
Property and Equipment Excluding Construction in Progress Gross | 1,026 | 1,026 |
Capital Lease - Vehicles [Member] | ||
Property Plant And Equipment [Line Items] | ||
Property and Equipment Excluding Construction in Progress Gross | 4,050 | 3,782 |
Manufacturing Equipment [Member] | ||
Property Plant And Equipment [Line Items] | ||
Property and Equipment Excluding Construction in Progress Gross | 389,503 | 306,036 |
Computer Equipment [Member] | ||
Property Plant And Equipment [Line Items] | ||
Property and Equipment Excluding Construction in Progress Gross | 27,301 | 24,927 |
Furniture and Fixtures [Member] | ||
Property Plant And Equipment [Line Items] | ||
Property and Equipment Excluding Construction in Progress Gross | 6,013 | 5,689 |
Vehicles [Member] | ||
Property Plant And Equipment [Line Items] | ||
Property and Equipment Excluding Construction in Progress Gross | 588 | 465 |
Construction in Progress [Member] | ||
Property Plant And Equipment [Line Items] | ||
Property and Equipment, Gross | $ 77,705 | $ 54,412 |
Property, Plant and Equipment_4
Property, Plant and Equipment - Net - Additional Information (Detail) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | |||
Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | Sep. 30, 2020 | |
Property Plant And Equipment [Line Items] | |||||
Finance lease right of use asset | $ 9,200 | $ 9,200 | $ 9,200 | ||
Finance lease obligation | 7,900 | 7,900 | 7,900 | ||
Depreciation | 13,300 | $ 12,700 | 37,588 | $ 33,603 | |
Interest Capitalized | 500 | $ 300 | 1,400 | $ 800 | |
Assets Under Capital Lease [Member] | |||||
Property Plant And Equipment [Line Items] | |||||
Accumulated amortization under capital leases | 4,600 | 4,600 | 4,000 | ||
Assets under Build to Suit lease [Member] | |||||
Property Plant And Equipment [Line Items] | |||||
Accumulated amortization leased assets | $ 800 | $ 800 | $ 500 |
Goodwill and Intangible Asset_3
Goodwill and Intangible Assets - Net - Additional Information (Detail) - USD ($) | 3 Months Ended | 9 Months Ended | |||
Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | Sep. 30, 2020 | |
Goodwill [Line Items] | |||||
Goodwill | $ 951,390,000 | $ 951,390,000 | $ 951,390,000 | ||
Accumulated goodwill impairments | 32,200,000 | 32,200,000 | |||
Indefinite lived intangible assets other than goodwill | 0 | 0 | 0 | ||
Amortization expense | 12,500,000 | $ 13,900,000 | $ 37,666,000 | $ 41,622,000 | |
Acquired finite lived intangible assets weighted average useful life | 12 years 4 months 24 days | ||||
Residential Segment [Member] | |||||
Goodwill [Line Items] | |||||
Goodwill | 911,000,000 | $ 911,000,000 | 911,000,000 | ||
Commercial Segment [Member] | |||||
Goodwill [Line Items] | |||||
Goodwill | $ 40,400,000 | $ 40,400,000 | $ 40,400,000 |
Goodwill and Intangible Asset_4
Goodwill and Intangible Assets - Net - Summary of Finite-Lived Intangible Assets (Detail) - USD ($) $ in Thousands | 9 Months Ended | 12 Months Ended |
Jun. 30, 2021 | Sep. 30, 2020 | |
Finite Lived Intangible Assets [Line Items] | ||
Gross Carrying Value | $ 670,886 | $ 670,886 |
Accumulated Amortization | (416,178) | (378,512) |
Net Carrying Value | 254,708 | 292,374 |
Proprietary Knowledge [Member] | ||
Finite Lived Intangible Assets [Line Items] | ||
Gross Carrying Value | 289,300 | 289,300 |
Accumulated Amortization | (211,114) | (195,303) |
Net Carrying Value | 78,186 | 93,997 |
Trademarks [Member] | ||
Finite Lived Intangible Assets [Line Items] | ||
Gross Carrying Value | 223,840 | 223,840 |
Accumulated Amortization | (135,904) | (124,521) |
Net Carrying Value | 87,936 | 99,319 |
Customer relationships [Member] | ||
Finite Lived Intangible Assets [Line Items] | ||
Gross Carrying Value | 146,670 | 146,670 |
Accumulated Amortization | (61,434) | (52,119) |
Net Carrying Value | $ 85,236 | $ 94,551 |
Patents [Member] | ||
Finite Lived Intangible Assets [Line Items] | ||
Lives in Years | 10 years | 10 years |
Gross Carrying Value | $ 7,000 | $ 7,000 |
Accumulated Amortization | (3,882) | (3,182) |
Net Carrying Value | 3,118 | 3,818 |
Other intangibles [Member] | ||
Finite Lived Intangible Assets [Line Items] | ||
Gross Carrying Value | 4,076 | 4,076 |
Accumulated Amortization | (3,844) | (3,387) |
Net Carrying Value | $ 232 | $ 689 |
Minimum [Member] | Proprietary Knowledge [Member] | ||
Finite Lived Intangible Assets [Line Items] | ||
Lives in Years | 10 years | 10 years |
Minimum [Member] | Trademarks [Member] | ||
Finite Lived Intangible Assets [Line Items] | ||
Lives in Years | 5 years | 5 years |
Minimum [Member] | Customer relationships [Member] | ||
Finite Lived Intangible Assets [Line Items] | ||
Lives in Years | 15 years | 15 years |
Minimum [Member] | Other intangibles [Member] | ||
Finite Lived Intangible Assets [Line Items] | ||
Lives in Years | 3 years | 3 years |
Maximum [Member] | Proprietary Knowledge [Member] | ||
Finite Lived Intangible Assets [Line Items] | ||
Lives in Years | 15 years | 15 years |
Maximum [Member] | Trademarks [Member] | ||
Finite Lived Intangible Assets [Line Items] | ||
Lives in Years | 20 years | 20 years |
Maximum [Member] | Customer relationships [Member] | ||
Finite Lived Intangible Assets [Line Items] | ||
Lives in Years | 19 years | 19 years |
Maximum [Member] | Other intangibles [Member] | ||
Finite Lived Intangible Assets [Line Items] | ||
Lives in Years | 15 years | 15 years |
Composition of Certain Balanc_3
Composition of Certain Balance Sheet Accounts - Summary of Allowance for Doubtful Accounts (Detail) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | |
Allowance For Credit Loss [Abstract] | ||||
Beginning balance | $ 1,487 | $ 1,678 | $ 1,332 | $ 904 |
Bad debt provision | 116 | (229) | 271 | 522 |
Bad debt write-offs | (540) | (107) | (540) | (119) |
Acquisition | 35 | |||
Ending balance | $ 1,063 | $ 1,342 | $ 1,063 | $ 1,342 |
Composition of Certain Balanc_4
Composition of Certain Balance Sheet Accounts - Summary of Accrued Expenses and Other Liabilities (Detail) - USD ($) $ in Thousands | Jun. 30, 2021 | Sep. 30, 2020 |
Accrued Liabilities And Other Liabilities [Abstract] | ||
Employee related liabilities | $ 30,949 | $ 26,554 |
Freight | 3,277 | 5,530 |
Professional fees | 4,030 | 4,249 |
Marketing | 3,491 | 3,343 |
Warranty | 2,977 | 2,921 |
Construction in progress | 2,250 | 1,303 |
Capital lease | 1,064 | 969 |
Manufacturing related accruals | 1,816 | 1,664 |
Other | 4,056 | 3,983 |
Ending balance | $ 53,910 | $ 50,516 |
Debt - Additional Information (
Debt - Additional Information (Detail) - USD ($) $ in Thousands | Feb. 02, 2021 | Jun. 16, 2020 | May 12, 2020 | May 07, 2020 | Sep. 30, 2013 | Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | Sep. 30, 2020 | Mar. 31, 2021 |
Debt Instrument [Line Items] | |||||||||||
Deferred financing cost | $ 2,879 | $ 2,879 | $ 4,165 | ||||||||
Term loan outstanding | 467,310 | 467,310 | $ 467,147 | ||||||||
Interest expense | 4,219 | $ 25,148 | 16,931 | $ 64,882 | |||||||
Cash paid for interest, net of amounts capitalized | $ 14,871 | 70,801 | |||||||||
Gain (loss) on extinguishment of debt | (37,538) | (37,538) | |||||||||
CPG International LLC [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt instrument, covenant description | CPG International LLC is also required to make mandatory prepayments (i) when aggregate borrowings exceed commitments or the applicable borrowing base and (ii) during “cash dominion,” which occurs if (a) the availability under the Revolving Credit Facility is less than the greater of (i) $12.5 million and (ii) 10% of the lesser of (x) $150.0 million and (y) the borrowing base, for five consecutive business days or (b) certain events of default have occurred and are continuing. | ||||||||||
Maximum [Member] | CPG International LLC [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Minimum fixed charge coverage ratio | 100 | ||||||||||
Minimum [Member] | CPG International LLC [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Minimum fixed charge coverage ratio | 100 | ||||||||||
Revolving Credit Facility [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt instrument maturity date | Mar. 31, 2026 | ||||||||||
Debt instrument, description of variable rate basis | LIBOR + 1.25 | LIBOR +2.00 | |||||||||
Debt instrument interest rate description | interest rate has been reduced by 25 basis points to (i) for ABR borrowings, the highest of (a) the Federal Funds Rate plus 50 basis points, (b) the prime rate and (c) the LIBOR as of such date for a deposit in U.S. dollars with a maturity of one month plus 100 basis points, plus, in each case, a spread of 25 to 75 basis points, based on average historical availability, or (ii) for Eurocurrency borrowings, adjusted LIBOR plus a spread of 125 to 175 basis points, based on average historical availability. | ||||||||||
Debt instrument, basis spread on variable rate | 1.25% | 2.00% | |||||||||
Aggregate maximum borrowing capacity | 150,000 | $ 150,000 | |||||||||
Outstanding borrowings capacity | $ 70,000 | 4,400 | 4,400 | $ 6,800 | |||||||
Option to increase the commitments | 100,000 | $ 100,000 | |||||||||
Outstanding letters of credit held | 800 | $ 1,300 | |||||||||
Line of credit facility, commitment fee description | If the average daily used percentage is greater than 50%, the commitment fee equals 25 basis points, and if the average daily used percentage is less than or equal to 50%, the commitment fee equals 37.5 basis points. | ||||||||||
Line of credit facility, commitment fee amount | 100 | 100 | $ 400 | $ 300 | |||||||
Debt instrument, covenant description | (i) 10% of the lesser of the aggregate commitments under the Revolving Credit Facility and the borrowing base, and (ii) $12.5 million | ||||||||||
Revolving Credit Facility [Member] | CPG International LLC [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Available borrowing capacity | 145,600 | $ 145,600 | |||||||||
Revolving Credit Facility [Member] | ABR Borrowings [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt instrument interest rate description | (i) for ABR borrowings, the highest of (a) the Federal Funds Rate plus 50 basis points, (b) the prime rate and (c) the LIBOR as of such date for a deposit in U.S. dollars with a maturity of one month plus 100 basis points, plus, in each case, a spread of 25 to 75 basis points, based on average historical availability, or (ii) for Eurocurrency borrowings, adjusted LIBOR plus a spread of 125 to 175 basis points, based on average historical availability. | ||||||||||
Revolving Credit Facility [Member] | ABR Borrowings [Member] | Fed Funds Effective Rate Overnight Index Swap Rate [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt instrument, description of variable rate basis | Federal Funds Rate plus 50 basis points | ||||||||||
Revolving Credit Facility [Member] | ABR Borrowings [Member] | London Interbank Offered Rate (LIBOR) [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt instrument, description of variable rate basis | LIBOR as of such date for a deposit in U.S. dollars with a maturity of one month plus 100 basis points, plus, in each case, a spread of 25 to 75 basis points | ||||||||||
Revolving Credit Facility [Member] | ABR Borrowings [Member] | Prime Rate [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt instrument, description of variable rate basis | prime rate | ||||||||||
Revolving Credit Facility [Member] | Eurocurrency Borrowings [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt instrument interest rate description | for Eurocurrency borrowings, adjusted LIBOR plus a spread of 125 to 175 basis points, based on average historical availability | ||||||||||
Revolving Credit Facility [Member] | Eurocurrency Borrowings [Member] | London Interbank Offered Rate (LIBOR) [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt instrument, description of variable rate basis | LIBOR plus a spread of 125 to 175 basis points | ||||||||||
Revolving Credit Facility [Member] | Maximum [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt instrument maturity date | Mar. 31, 2026 | ||||||||||
Revolving Credit Facility [Member] | Minimum [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt instrument maturity date | May 9, 2022 | ||||||||||
Amended Agreement For Term Loan [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Interest expense | $ 600 | ||||||||||
Lender fees | 100 | 100 | |||||||||
Reduction of long-term debt | 3,600 | ||||||||||
Amended Agreement For Term Loan [Member] | Interest Expense | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Third-party fees and expenses related to the term loan amendment | 900 | ||||||||||
Amended Agreement For Term Loan [Member] | CPG International LLC [Member] | Wilmington Trust National Association [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Deferred financing cost | 2,900 | $ 2,900 | 4,200 | ||||||||
Term loan frequency of instalment payment | quarterly installments | ||||||||||
Percentage of principal amount to be repaid by way of instalments | 0.25253% | ||||||||||
Prepay of outstanding principal of term loan agreement | $ 337,700 | ||||||||||
Amended Agreement For Revolving Credit Facility [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Deferred financing cost | 500 | $ 500 | |||||||||
Interest expense | 100 | ||||||||||
Lender fees | 900 | $ 900 | |||||||||
Term Loan [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt instrument maturity date | May 5, 2024 | ||||||||||
Term loan outstanding | $ 467,310 | $ 467,310 | $ 467,147 | ||||||||
Debt instrument, description of variable rate basis | LIBOR + 2.50% | LIBOR + 3.75% | |||||||||
Debt instrument, basis spread on variable rate | 2.50% | 3.75% | |||||||||
2021 Senior Notes [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt instrument maturity date | Oct. 1, 2021 | Oct. 1, 2021 | |||||||||
Debt instrument interest rate | 8.00% | 8.00% | 8.00% | ||||||||
Debt instrument face amount | $ 315,000 | ||||||||||
Debt instrument, repurchase amount | $ 315,000 | ||||||||||
Debt Instrument, Repurchase Date | Jun. 8, 2020 | ||||||||||
Term Loan Agreement [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt instrument maturity date | May 5, 2024 | ||||||||||
Debt instrument interest rate description | (i) the ABR floor by 25 basis points from 2.0% to 1.75%, (ii) the Adjusted LIBOR Rate floor by 25 basis points from 1.0% to 0.75% and (iii) the Applicable Margin with respect to any Effective Date Term Loans, by up to 125 basis points from 3.75% to 2.50% in the case of any Eurocurrency Loan and by up to 125 basis points from 2.75% to 1.50% in the case of any ABR Loan. The Applicable Margin may be reduced by a further 25 basis points in respect of both Eurocurrency Loans and ABR Loans during any period that the Borrower maintains specified public corporate family ratings. | ||||||||||
Term Loan Agreement [Member] | London Interbank Offered Rate (LIBOR) [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt instrument, description of variable rate basis | Adjusted LIBOR Rate floor by 25 basis points from 1.0% to 0.75% | ||||||||||
Term Loan Agreement [Member] | ABR Floor [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt instrument, description of variable rate basis | ABR floor by 25 basis points from 2.0% to 1.75% | ||||||||||
Term Loan Agreement [Member] | CPG International LLC [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Term loan outstanding | $ 467,700 | $ 467,700 | $ 467,700 | ||||||||
Term Loan Agreement [Member] | Eurocurrency Loan [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt instrument, description of variable rate basis | Term Loans, by up to 125 basis points from 3.75% to 2.50% in the case of any Eurocurrency Loan | ||||||||||
Term Loan Agreement [Member] | ABR Loan [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt instrument, description of variable rate basis | up to 125 basis points from 2.75% to 1.50% in the case of any ABR Loan | ||||||||||
Term Loan Agreement [Member] | Maximum [Member] | London Interbank Offered Rate (LIBOR) [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt instrument, basis spread on variable rate | 1.00% | ||||||||||
Term Loan Agreement [Member] | Maximum [Member] | ABR Floor [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt instrument, basis spread on variable rate | 2.00% | ||||||||||
Term Loan Agreement [Member] | Maximum [Member] | Eurocurrency Loan [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt instrument, basis spread on variable rate | 3.75% | ||||||||||
Term Loan Agreement [Member] | Maximum [Member] | ABR Loan [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt instrument, basis spread on variable rate | 2.75% | ||||||||||
Term Loan Agreement [Member] | Minimum [Member] | London Interbank Offered Rate (LIBOR) [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt instrument, basis spread on variable rate | 0.75% | ||||||||||
Term Loan Agreement [Member] | Minimum [Member] | ABR Floor [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt instrument, basis spread on variable rate | 1.75% | ||||||||||
Term Loan Agreement [Member] | Minimum [Member] | Eurocurrency Loan [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt instrument, basis spread on variable rate | 2.50% | ||||||||||
Term Loan Agreement [Member] | Minimum [Member] | ABR Loan [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt instrument, basis spread on variable rate | 1.50% | ||||||||||
2025 Senior Notes [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt instrument maturity date | May 15, 2025 | ||||||||||
Debt instrument interest rate | 9.50% | ||||||||||
Debt instrument face amount | $ 350,000 | ||||||||||
Debt Instrument, Redemption Price, Percentage | 107.125% | ||||||||||
Repayment of debt | 350,000 | ||||||||||
Cash paid for interest, net of amounts capitalized | 3,900 | ||||||||||
Gain (loss) on extinguishment of debt | $ 35,600 |
Debt - Summary of Long-Term Deb
Debt - Summary of Long-Term Debt (Detail) - USD ($) $ in Thousands | Jun. 30, 2021 | Sep. 30, 2020 |
Debt Instrument [Line Items] | ||
Long-term Debt, Gross | $ 467,310 | $ 467,147 |
Less unamortized deferred financing costs | (2,879) | (4,165) |
Long-term debt—less current portion and unamortized deferred financing costs | 464,431 | 462,982 |
Term Loan [Member] | ||
Debt Instrument [Line Items] | ||
Long-term Debt, Gross | $ 467,310 | $ 467,147 |
Debt - Summary of Long-Term D_2
Debt - Summary of Long-Term Debt (Detail) (Parenthetical) - USD ($) $ in Thousands | 1 Months Ended | 9 Months Ended | 12 Months Ended |
Sep. 30, 2013 | Jun. 30, 2021 | Sep. 30, 2020 | |
Term Loan [Member] | |||
Debt Instrument [Line Items] | |||
Debt instrument maturity date | May 5, 2024 | ||
Debt instrument, description of variable rate basis | LIBOR + 2.50% | LIBOR + 3.75% | |
Debt instrument, basis spread on variable rate | 2.50% | 3.75% | |
Debt instrument rate | 3.25% | 4.75% | |
Debt instrument unamortized discount | $ 344 | $ 507 | |
2021 Senior Notes [Member] | |||
Debt Instrument [Line Items] | |||
Debt instrument maturity date | Oct. 1, 2021 | Oct. 1, 2021 | |
Debt instrument fixed interest rate | 8.00% | 8.00% | |
Revolving Credit Facility [Member] | |||
Debt Instrument [Line Items] | |||
Debt instrument maturity date | Mar. 31, 2026 | ||
Debt instrument, description of variable rate basis | LIBOR + 1.25 | LIBOR +2.00 | |
Debt instrument, basis spread on variable rate | 1.25% | 2.00% |
Debt - Disclosure of Debt Instr
Debt - Disclosure of Debt Instrument Redemption (Detail) - 2021 Senior Notes [Member] | 12 Months Ended |
Sep. 30, 2017 | |
Debt Instrument, Redemption, Period One [Member] | |
Debt Instrument, Redemption [Line Items] | |
Debt Instrument, Redemption Price, Percentage | 106.00% |
Debt Instrument, Redemption, Period Two [Member] | |
Debt Instrument, Redemption [Line Items] | |
Debt Instrument, Redemption Price, Percentage | 104.00% |
Debt Instrument, Redemption, Period Three [Member] | |
Debt Instrument, Redemption [Line Items] | |
Debt Instrument, Redemption Price, Percentage | 102.00% |
Debt Instrument, Redemption, Period Four [Member] | |
Debt Instrument, Redemption [Line Items] | |
Debt Instrument, Redemption Price, Percentage | 100.00% |
Debt - Summary of Interest Expe
Debt - Summary of Interest Expense (Detail) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | |
Interest Expense | ||||
Other | $ 363 | $ 380 | $ 1,109 | $ 1,155 |
Amortization - Debt issue costs | ||||
Capitalized interest | (491) | (270) | (1,427) | (849) |
Interest expense | 4,219 | 25,148 | 16,931 | 64,882 |
Term Loan [Member] | ||||
Interest Expense | ||||
Interest Expense, debt | 3,842 | 11,228 | 13,942 | 35,584 |
Amortization - Debt issue costs | ||||
Amortization of debt issuance costs | 254 | 3,630 | 2,243 | 4,620 |
Term Loan OID | 30 | 442 | 162 | 562 |
2021 Senior Notes [Member] | ||||
Interest Expense | ||||
Interest Expense, debt | 4,550 | 17,150 | ||
Amortization - Debt issue costs | ||||
Amortization of debt issuance costs | 176 | 880 | ||
2025 Senior Notes [Member] | ||||
Interest Expense | ||||
Interest Expense, debt | 3,879 | 3,879 | ||
Amortization - Debt issue costs | ||||
Amortization of debt issuance costs | 180 | 180 | ||
Revolving Credit Facility [Member] | ||||
Interest Expense | ||||
Interest Expense, debt | 156 | 846 | 473 | 1,434 |
Amortization - Debt issue costs | ||||
Amortization of debt issuance costs | $ 65 | $ 107 | $ 429 | $ 287 |
Product Warranties - Additional
Product Warranties - Additional Information (Detail) | 9 Months Ended |
Jun. 30, 2021 | |
Product Warranties Disclosures [Abstract] | |
Assurance of product | The Company provides product assurance warranties of various lengths ranging from 5 years to lifetime for limited coverage for a variety of material and workmanship defects based on standard terms and conditions between the Company and its customers. |
Product Warranties - Summary of
Product Warranties - Summary of Warranty Reserve Activity (Detail) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | |
Product Warranties Disclosures [Abstract] | ||||
Beginning balance | $ 12,065 | $ 11,984 | $ 10,913 | $ 11,133 |
Adjustments to reserve | 1,720 | 35 | 4,270 | 2,226 |
Warranty claims payment | (843) | (770) | (2,269) | (2,247) |
Accretion - purchase accounting valuation | 28 | 28 | 165 | |
Ending balance | 12,942 | 11,277 | 12,942 | 11,277 |
Current portion of accrued warranty | (2,977) | (3,375) | (2,977) | (3,375) |
Accrued warranty – less current portion | $ 9,965 | $ 7,902 | $ 9,965 | $ 7,902 |
Fair Value Of Financial Instr_3
Fair Value Of Financial Instruments - Summary of Carrying Values and the Estimated Fair Values of the Debt Financial Instruments (Detail) - Fair Value, Inputs, Level 2 [Member] - USD ($) $ in Thousands | Jun. 30, 2021 | Sep. 30, 2020 |
Carrying Value [Member] | ||
Schedule of carrying values and the estimated fair values of the debt financial instruments [Line Items] | ||
Term Loan due May 5, 2024 | $ 467,310 | $ 467,147 |
Estimated Fair Value [Member] | ||
Schedule of carrying values and the estimated fair values of the debt financial instruments [Line Items] | ||
Term Loan due May 5, 2024 | $ 466,719 | $ 465,185 |
Segment - Additional Informatio
Segment - Additional Information (Detail) | 9 Months Ended |
Jun. 30, 2021Segment | |
Segment Reporting [Abstract] | |
Number of Reportable Segments | 2 |
Segments - Summary of Residenti
Segments - Summary of Residential and Commercial Segment Reporting Information (Detail) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | |
Segment Reporting Information [Line Items] | ||||
Net sales to customers | $ 327,454 | $ 223,711 | $ 832,854 | $ 635,339 |
Adjusted EBITDA | ||||
Total Adjusted EBITDA for reporting segments | 88,798 | 67,350 | 236,303 | 175,226 |
Unallocated net expenses | (16,082) | (9,530) | (43,623) | (27,782) |
Adjustments to Income (loss) before income tax provision | ||||
Depreciation and amortization | (25,736) | (26,597) | (75,255) | (75,225) |
Stock-based compensation costs | (9,510) | (18,788) | (19,646) | (20,169) |
Business transformation costs | (109) | (435) | ||
Acquisition costs | (182) | (1,538) | ||
Initial public offering costs and Secondary offering costs | (1,443) | (1,623) | (2,592) | (6,716) |
Capital structure transaction costs | (37,538) | (37,538) | ||
Other costs | (1,228) | (2,551) | (3,922) | (3,015) |
Interest expense, net | (4,219) | (25,148) | (16,931) | (64,882) |
Income (loss) before income taxes | 30,580 | (54,716) | 74,334 | (62,074) |
Residential [Member] | ||||
Segment Reporting Information [Line Items] | ||||
Net sales to customers | 291,209 | 192,599 | 739,048 | 538,514 |
Adjusted EBITDA | ||||
Total Adjusted EBITDA for reporting segments | 82,525 | 62,326 | 222,999 | 164,047 |
Commercial [Member] | ||||
Segment Reporting Information [Line Items] | ||||
Net sales to customers | 36,245 | 31,112 | 93,806 | 96,825 |
Adjusted EBITDA | ||||
Total Adjusted EBITDA for reporting segments | $ 6,273 | $ 5,024 | $ 13,304 | $ 11,179 |
Segments - Summary of Residen_2
Segments - Summary of Residential and Commercial Segment Reporting Information (Parenthetical) (Detail) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | |
Business Transformation Costs [Line Items] | ||||
Business acquisition acquisition costs completed acquisitions | $ 100 | $ 900 | ||
Inventory step up adjustments relating to business acquisitions | 100 | 600 | ||
Legal expenses | $ 800 | 400 | $ 1,800 | 400 |
Capital structure transaction costs | 37,538 | 37,538 | ||
Costs of reduction in workforce | 400 | 400 | ||
2021 Senior Notes [Member] | ||||
Business Transformation Costs [Line Items] | ||||
Capital structure transaction costs | 1,900 | |||
2025 Senior Notes [Member] | ||||
Business Transformation Costs [Line Items] | ||||
Capital structure transaction costs | 35,600 | |||
IPO [Member] | ||||
Business Transformation Costs [Line Items] | ||||
Costs related to an incentive plan | $ 400 | 1,800 | $ 2,100 | 2,200 |
Business Transformation Costs [Member] | ||||
Business Transformation Costs [Line Items] | ||||
Compensation costs for transformation | $ 100 | $ 400 |
Capital Stock - Additional Info
Capital Stock - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands | Jun. 01, 2021 | Jan. 26, 2021 | Sep. 15, 2020 | Jun. 16, 2020 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | Sep. 30, 2020 |
Class Of Stock [Line Items] | ||||||||
Proceeds from issuance initial public offering | $ 819,700 | $ (210) | $ 822,630 | |||||
Underwriting commission and discounts | 50,600 | |||||||
Estimated offering expenses payable | $ 9,200 | |||||||
Preferred stock, shares authorized | 1,000,000 | 1,000,000 | ||||||
Preferred stock, par value per share | $ 0.001 | $ 0.001 | ||||||
Common stock description of voting rights | The Class A common stock and Class B common stock provide identical economic rights, but holders of Class B common stock have limited voting rights, specifically that such holders have no right to vote, solely with respect to their shares of Class B common stock, with respect to the election, replacement or removal of directors. | |||||||
Common stock description of conversion rights | Class A common stock and Class B common stock are not entitled to preemptive rights. Holders of Class B common stock may convert their shares of Class B common stock into shares of Class A common stock on a one-for-one basis, in whole or in part, at any time and from time to time at their option. | |||||||
Conversion of Units of Limited Liability Company [Member] | ||||||||
Class Of Stock [Line Items] | ||||||||
Common stock member interests converted | 108,162,741 | |||||||
Conversion of Membership Interests in Limited Liability Company [Member] | ||||||||
Class Of Stock [Line Items] | ||||||||
Common stock member interests converted | 108,162,741 | |||||||
Common Class A [Member] | ||||||||
Class Of Stock [Line Items] | ||||||||
Shares issued during period | 38,237,500 | 38,237,500 | ||||||
Common stock, shares authorized | 1,100,000,000 | 1,100,000,000 | ||||||
Common stock par or stated value per share | $ 0.001 | $ 0.001 | ||||||
Common Class A [Member] | Conversion of Units of Limited Liability Company [Member] | ||||||||
Class Of Stock [Line Items] | ||||||||
Common stock member interests converted | 75,093,778 | |||||||
Common Class A [Member] | Conversion of Membership Interests in Limited Liability Company [Member] | ||||||||
Class Of Stock [Line Items] | ||||||||
Common stock member interests converted | 75,093,778 | |||||||
Common Class A [Member] | Conversion of Profit Interests [Member] | ||||||||
Class Of Stock [Line Items] | ||||||||
Common stock member interests converted | 2,703,243 | |||||||
Common Class B [Member] | ||||||||
Class Of Stock [Line Items] | ||||||||
Common stock, shares authorized | 100,000,000 | 100,000,000 | ||||||
Common stock par or stated value per share | $ 0.001 | $ 0.001 | ||||||
Common stock member interests converted | 33,068,863 | |||||||
Common Class B [Member] | Conversion of Units of Limited Liability Company [Member] | ||||||||
Class Of Stock [Line Items] | ||||||||
Common stock member interests converted | 33,068,963 | |||||||
Common Class B [Member] | Conversion of Membership Interests in Limited Liability Company [Member] | ||||||||
Class Of Stock [Line Items] | ||||||||
Common stock member interests converted | 33,068,963 | |||||||
Class A Restricted Stock [Member] | Conversion of Profit Interests [Member] | ||||||||
Class Of Stock [Line Items] | ||||||||
Common stock member interests converted | 5,532,037 | |||||||
IPO [Member] | ||||||||
Class Of Stock [Line Items] | ||||||||
Shares issued during period | 38,237,500 | |||||||
Shares issued price | $ 23 | |||||||
IPO [Member] | Common Class A [Member] | ||||||||
Class Of Stock [Line Items] | ||||||||
Shares issued during period | 38,237,500 | |||||||
Over-Allotment Option [Member] | ||||||||
Class Of Stock [Line Items] | ||||||||
Shares issued during period | 4,987,500 | |||||||
Over-Allotment Option [Member] | Common Class A [Member] | ||||||||
Class Of Stock [Line Items] | ||||||||
Shares issued price | $ 43.50 | $ 40 | $ 33.25 | |||||
Overallotment stock shares sold by shareholders during the period | 2,250,000 | 3,000,000 | 3,750,000 | |||||
Employee Stock [Member] | Common Class A [Member] | ||||||||
Class Of Stock [Line Items] | ||||||||
Common stock shares reserved for future issuance | 3,477,413 | |||||||
Secondary Offering [Member] | Common Class A [Member] | ||||||||
Class Of Stock [Line Items] | ||||||||
Common stock par or stated value per share | $ 0.001 | $ 0.001 | $ 0.001 | |||||
Stock shares sold by shareholders during the period | 17,250,000 | 20,000,000 | 28,750,000 | |||||
Estimated offering expenses | $ 1,100 | $ 1,200 |
Stock-Based Compensation - Addi
Stock-Based Compensation - Additional Information (Detail) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Stock based compensation expenses | $ 9,510 | $ 18,788 | $ 19,646 | $ 20,169 |
Income tax benefit stock based compensation expenses | 1,200 | 1,600 | 2,000 | 1,600 |
Unvested stock compensation not recognised | $ 25,600 | 25,600 | ||
Unvested stock awards weighted average remaining period of recognition | 2 years 6 months | |||
Selling, General and Administrative Expenses [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Stock based compensation expenses | $ 9,500 | $ 18,800 | $ 19,600 | $ 20,200 |
2020 Omnibus Incentive Compensation Plan [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Maximum number of shares authorised under share based compensation plan | 15,852,319 | 15,852,319 | ||
Common stock shares reserved for future issuance | 4,597,638 | 4,597,638 | ||
Stock based compensation period of expiry of stock options | 10 years | |||
CFOs Awards [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Stock based compensation expenses | $ 5,100 | $ 8,800 |
Stock-Based Compensation - Summ
Stock-Based Compensation - Summary of Stock Option Activities (Detail) - USD ($) $ / shares in Units, $ in Thousands | 9 Months Ended |
Jun. 30, 2021 | |
Performance Shares [Member] | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Number of Option, Outstanding | 1,705,498 |
Number of Option, Granted | |
Number of Option, Exercised | (132,705) |
Number of Option, Cancelled/Forfeited | |
Number of Option, Outstanding | 1,572,793 |
Number of Option, Vested and exercisable | 1,572,793 |
Weighted Average Exercise Price Per Share, Outstanding | $ 23 |
Weighted Average Exercise Price Per Share, Granted | 0 |
Weighted Average Exercise Price Per Share, Exercised | 23 |
Weighted Average Exercise Price Per Share, Cancelled/Forfeited | 0 |
Weighted Average Exercise Price Per Share, Outstanding | 23 |
Weighted Average Exercise Price Per Share, Vested and exercisable | $ 23 |
Weighted Average Remaining Contract Term, Outstanding | 8 years 10 months 24 days |
Weighted Average Remaining Contract Term, Vested and exercisable | 8 years 10 months 24 days |
Weighted Average Intrinsic Value, Outstanding | $ 30,607 |
Weighted Average Intrinsic Value, Vested and exercisable | $ 30,607 |
Service Based Stock Option Activity [Member] | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Number of Option, Outstanding | 3,382,947 |
Number of Option, Granted | 117,989 |
Number of Option, Exercised | (70,924) |
Number of Option, Cancelled/Forfeited | (46,437) |
Number of Option, Outstanding | 3,383,575 |
Number of Option, Vested and exercisable | 1,585,280 |
Weighted Average Exercise Price Per Share, Outstanding | $ 23 |
Weighted Average Exercise Price Per Share, Granted | 34.27 |
Weighted Average Exercise Price Per Share, Exercised | 23 |
Weighted Average Exercise Price Per Share, Cancelled/Forfeited | 23 |
Weighted Average Exercise Price Per Share, Outstanding | 23.39 |
Weighted Average Exercise Price Per Share, Vested and exercisable | $ 23 |
Weighted Average Remaining Contract Term, Outstanding | 9 years |
Weighted Average Remaining Contract Term, Vested and exercisable | 8 years 10 months 24 days |
Weighted Average Intrinsic Value, Outstanding | $ 64,515 |
Weighted Average Intrinsic Value, Vested and exercisable | $ 30,850 |
Stock-Based Compensation - Su_2
Stock-Based Compensation - Summary of Stock Awards Activity Other Than Options (Detail) | 9 Months Ended |
Jun. 30, 2021$ / sharesshares | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Number of Shares, Outstanding and unvested | shares | 184,851 |
Number of Shares, Granted | shares | 197,098 |
Number of Shares, Vested | shares | (14,681) |
Number of Shares, Forfeited | shares | (20,519) |
Number of Shares, Outstanding and unvested | shares | 346,749 |
Weighted Average Grant Date Fair Value, Outstanding and unvested | $ / shares | $ 23 |
Weighted Average Grant Date Fair Value, Granted | $ / shares | 35.92 |
Weighted Average Grant Date Fair Value, Vested | $ / shares | 29.92 |
Weighted Average Grant Date Fair Value, Outstanding and unvested | $ / shares | $ 29.89 |
Service Based Restricted Stock [Member] | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Number of Shares, Outstanding and unvested | shares | 1,485,611 |
Number of Shares, Granted | shares | |
Number of Shares, Vested | shares | (622,644) |
Number of Shares, Forfeited | shares | (26,394) |
Number of Shares, Outstanding and unvested | shares | 836,573 |
Weighted Average Grant Date Fair Value, Outstanding and unvested | $ / shares | $ 23 |
Weighted Average Grant Date Fair Value, Granted | $ / shares | |
Weighted Average Grant Date Fair Value, Vested | $ / shares | 23 |
Weighted Average Grant Date Fair Value, Forfeited | $ / shares | 23 |
Weighted Average Grant Date Fair Value, Outstanding and unvested | $ / shares | $ 23 |
Performance Based Restricted Stock [Member] | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Number of Shares, Outstanding and unvested | shares | |
Number of Shares, Granted | shares | 115,562 |
Number of Shares, Vested | shares | |
Number of Shares, Forfeited | shares | (2,659) |
Number of Shares, Outstanding and unvested | shares | 112,903 |
Weighted Average Grant Date Fair Value, Outstanding and unvested | $ / shares | |
Weighted Average Grant Date Fair Value, Granted | $ / shares | 34.98 |
Weighted Average Grant Date Fair Value, Vested | $ / shares | |
Weighted Average Grant Date Fair Value, Forfeited | $ / shares | 34.27 |
Weighted Average Grant Date Fair Value, Outstanding and unvested | $ / shares | $ 34.99 |
Stock-Based Compensation - Su_3
Stock-Based Compensation - Summary of Restricted Stock Unit Awards Activity (Detail) | 9 Months Ended |
Jun. 30, 2021USD ($)$ / sharesshares | |
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] | |
Number of Shares, Outstanding and unvested | shares | 184,851 |
Number of Shares, Granted | shares | 197,098 |
Number of Shares, Vested | shares | (14,681) |
Number of Shares, Forfeited | shares | (20,519) |
Number of Shares, Outstanding and unvested | shares | 346,749 |
Weighted Average Grant Date Fair Value, Outstanding and unvested | $ / shares | $ 23 |
Weighted Average Grant Date Fair Value, Granted | $ / shares | 35.92 |
Weighted Average Grant Date Fair Value, Vested | $ / shares | $ 29.92 |
Weighted Average Grant Date Fair Value, Forfeited | $ | $ 25.96 |
Weighted Average Grant Date Fair Value, Outstanding and unvested | $ / shares | $ 29.89 |
Earnings Per Share - Summary of
Earnings Per Share - Summary of Computation of Basic and Diluted Earnings Per Share (Detail) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | |
Numerator: | ||||
Net income (loss) | $ 21,769 | $ (52,116) | $ 54,609 | $ (57,874) |
Net income (loss) attributable to common stockholders- basic and diluted | $ 21,769 | $ (52,116) | $ 54,609 | $ (57,874) |
Denominator: | ||||
Basic | 153,854,313 | 118,738,357 | 153,623,579 | 113,525,537 |
Diluted | 157,022,043 | 118,738,357 | 156,658,640 | 113,525,537 |
Net income (loss) per common share - basic | $ 0.14 | $ 0.44 | $ 0.36 | $ (0.51) |
Net income (loss) per common share - diluted | $ 0.14 | $ 0.44 | $ 0.35 | $ (0.51) |
Earnings Per Share - Summary _2
Earnings Per Share - Summary of Antidilutive Securities Excluded From Computation of Earnings Per Share (Detail) - shares | 3 Months Ended | 9 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | |
Restricted Stock [Member] | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 1,143,949 | 381,316 | ||
Stock Options [Member] | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 992,632 | 83,412 | 330,877 | |
Restricted Stock Units [Member] | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 5,207 | 32,877 | 5,160 | 10,959 |
Income Taxes - Additional Infor
Income Taxes - Additional Information (Detail) | 3 Months Ended | 9 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | |
Income Tax Disclosure [Abstract] | ||||
Effective income tax reconcilation percentage | 28.80% | 4.80% | 26.50% | 6.80% |
Commitments And Contingencies -
Commitments And Contingencies - Additional Information (Detail) $ in Millions | 3 Months Ended | 9 Months Ended | 12 Months Ended | |||
Jun. 30, 2021USD ($)ft² | Jun. 30, 2020USD ($) | Jun. 30, 2021USD ($)ft² | Jun. 30, 2020USD ($) | Sep. 30, 2018USD ($) | Sep. 30, 2019USD ($) | |
Loss Contingencies [Line Items] | ||||||
Finance lease right of use asset | $ 9.2 | $ 9.2 | ||||
Finance lease incremental borrowing rate | 8.40% | 8.40% | ||||
Lease rental expenses | $ 1 | $ 0.4 | $ 2.4 | $ 1.1 | ||
Future minimum sublease income receivable | $ 0.7 | $ 0.7 | ||||
Minimum [Member] | Workmen Compensation [Member] | ||||||
Loss Contingencies [Line Items] | ||||||
Estimate Of Possible Loss | $ 0.4 | |||||
Maximum [Member] | Workmen Compensation [Member] | ||||||
Loss Contingencies [Line Items] | ||||||
Estimate Of Possible Loss | $ 0.5 | |||||
Leasehold Improvements [Member] | ||||||
Loss Contingencies [Line Items] | ||||||
Lease improvements expenditure incurred | $ 3.4 | |||||
Boise Lease [Member] | ||||||
Loss Contingencies [Line Items] | ||||||
Lease, term of contract | 15 years | 15 years | ||||
Area of lease property | ft² | 350,000 | 350,000 | ||||
Estimated lease payments | $ 40.3 | |||||
Boise Lease [Member] | Minimum [Member] | ||||||
Loss Contingencies [Line Items] | ||||||
Lease, renewal term | 5 years | 5 years | ||||
Boise Lease [Member] | Maximum [Member] | ||||||
Loss Contingencies [Line Items] | ||||||
Lease, renewal term | 20 years | 20 years |
Commitments And Contingencies_2
Commitments And Contingencies - Summary of Future Minimum Annual Payments Under Noncancelable Leases (Detail) $ in Thousands | Jun. 30, 2021USD ($) |
Commitments And Contingencies Disclosure [Abstract] | |
Remaining period of 2021 | $ 428 |
2022 | 1,616 |
2023 | 1,261 |
2024 | 892 |
2025 | 648 |
Thereafter | 2,191 |
Total Payments | 7,036 |
Less amount representing interest | (3,319) |
Present value of minimum capital lease payments | 3,717 |
Remaining period of 2021 | 193 |
2022 | 787 |
2023 | 806 |
2024 | 826 |
2025 | 846 |
Thereafter | 3,823 |
Total Payments | 7,281 |
Remaining period of 2021 | 1,035 |
2022 | 5,324 |
2023 | 5,538 |
2024 | 4,874 |
2025 | 4,441 |
Thereafter | 34,892 |
Total Payments | $ 56,104 |
Condensed Financial Informati_3
Condensed Financial Information of Registrant (Parent Company Only) - Schedule of Balance Sheets (Detail) - USD ($) $ in Thousands | Jun. 30, 2021 | Mar. 31, 2021 | Sep. 30, 2020 | Jun. 30, 2020 | Mar. 31, 2020 | Sep. 30, 2019 |
Non-current assets: | ||||||
Total assets | $ 2,043,975 | $ 1,931,856 | ||||
LIABILITIES AND STOCKHOLDERS' EQUITY: | ||||||
Total liabilities | 661,802 | 627,968 | ||||
Stockholders' equity: | ||||||
Preferred stock, $0.001 par value; 1,000,000 shares authorized and no shares issued and outstanding at June 30, 2021 and at September 30, 2020, respectively | ||||||
Additional paid‑in capital | 1,610,884 | 1,587,208 | ||||
Accumulated deficit | (228,866) | (283,475) | ||||
Total stockholders' equity | 1,382,173 | $ 1,349,403 | 1,303,888 | $ 1,269,513 | $ 485,406 | $ 490,023 |
Total liabilities and stockholders' equity | 2,043,975 | 1,931,856 | ||||
Parent Company [Member] | ||||||
Non-current assets: | ||||||
Investments in subsidiaries | 1,382,173 | 1,303,888 | ||||
Total non-current assets | 1,382,173 | 1,303,888 | ||||
Total assets | 1,382,173 | 1,303,888 | ||||
Stockholders' equity: | ||||||
Preferred stock, $0.001 par value; 1,000,000 shares authorized and no shares issued and outstanding at June 30, 2021 and at September 30, 2020, respectively | ||||||
Additional paid‑in capital | 1,610,884 | 1,587,208 | ||||
Accumulated deficit | (228,866) | (283,475) | ||||
Total stockholders' equity | 1,382,173 | 1,303,888 | ||||
Total liabilities and stockholders' equity | 1,382,173 | 1,303,888 | ||||
Common Class A [Member] | ||||||
Stockholders' equity: | ||||||
Common stock value | 155 | 155 | ||||
Total stockholders' equity | 155 | $ 155 | 155 | 122 | 75 | 75 |
Common Class A [Member] | Parent Company [Member] | ||||||
Stockholders' equity: | ||||||
Common stock value | $ 155 | $ 155 | ||||
Common Class B [Member] | ||||||
Stockholders' equity: | ||||||
Total stockholders' equity | $ 33 | $ 33 | $ 33 |
Condensed Financial Informati_4
Condensed Financial Information of Registrant (Parent Company Only) - Schedule of Balance Sheets (Parenthetical) (Detail) - $ / shares | Jun. 30, 2021 | Sep. 30, 2020 |
Preferred stock, par value per share | $ 0.001 | $ 0.001 |
Preferred stock, shares authorized | 1,000,000 | 1,000,000 |
Preferred stock, shares issued | 0 | 0 |
Preferred stock, shares outstanding | 0 | 0 |
Common Class A [Member] | ||
Common stock par or stated value per share | $ 0.001 | $ 0.001 |
Common stock, shares authorized | 1,100,000,000 | 1,100,000,000 |
Common stock, shares issued | 154,829,153 | 154,637,240 |
Common stock, shares outstanding | 154,829,153 | 154,637,240 |
Common Class B [Member] | ||
Common stock par or stated value per share | $ 0.001 | $ 0.001 |
Common stock, shares authorized | 100,000,000 | 100,000,000 |
Common stock, shares issued | 100 | 100 |
Common stock, shares outstanding | 100 | 100 |
Parent Company [Member] | ||
Preferred stock, par value per share | $ 0.001 | $ 0.001 |
Preferred stock, shares authorized | 1,000,000 | 1,000,000 |
Preferred stock, shares issued | 0 | 0 |
Preferred stock, shares outstanding | 0 | 0 |
Parent Company [Member] | Common Class A [Member] | ||
Common stock par or stated value per share | $ 0.001 | $ 0.001 |
Common stock, shares authorized | 1,100,000,000 | 1,100,000,000 |
Common stock, shares issued | 154,829,153 | 154,637,240 |
Common stock, shares outstanding | 154,829,153 | 154,637,240 |
Parent Company [Member] | Common Class B [Member] | ||
Common stock par or stated value per share | $ 0.001 | $ 0.001 |
Common stock, shares authorized | 100,000,000 | 100,000,000 |
Common stock, shares issued | 100 | 100 |
Common stock, shares outstanding | 100 | 100 |
Condensed Financial Informati_5
Condensed Financial Information of Registrant (Parent Company Only) - Schedule of Statements of Comprehensive Income (Loss) (Detail) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | |
Condensed Statement of Income Captions [Line Items] | ||||
Comprehensive income (loss) | $ 21,769 | $ (52,116) | $ 54,609 | $ (57,874) |
Parent Company [Member] | ||||
Condensed Statement of Income Captions [Line Items] | ||||
Net income (loss) of subsidiaries | 21,769 | (52,116) | 54,609 | (57,874) |
Comprehensive income (loss) | $ 21,769 | $ (52,116) | $ 54,609 | $ (57,874) |
Condensed Financial Informati_6
Condensed Financial Information of Registrant (Parent Company Only) - Additional Information (Detail) - Parent Company [Member] | 3 Months Ended | 9 Months Ended |
Jun. 30, 2021USD ($) | Jun. 30, 2021USD ($) | |
Condensed Statement of Income Captions [Line Items] | ||
Minimum threshold percentage of restricted net assets | 25.00% | 25.00% |
Cash dividends paid | $ 0 | $ 0 |